BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, Kelly C, Khoruts A, Louie T, Martinelli LP, Moore TA, Russell G, Surawicz C; Fecal Microbiota Transplantation Workgroup. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9:1044-1049. [PMID: 21871249 DOI: 10.1016/j.cgh.2011.08.014] [Cited by in Crossref: 575] [Cited by in F6Publishing: 503] [Article Influence: 52.3] [Reference Citation Analysis]
Number Citing Articles
1 Jalanka J, Hillamaa A, Satokari R, Mattila E, Anttila V, Arkkila P. The long-term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infection. Aliment Pharmacol Ther 2018;47:371-9. [DOI: 10.1111/apt.14443] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
2 Jørgensen SMD, Erikstrup C, Dinh KM, Lemming LE, Dahlerup JF, Hvas CL. Recruitment of feces donors among blood donors: Results from an observational cohort study. Gut Microbes 2018;9:540-50. [PMID: 29617178 DOI: 10.1080/19490976.2018.1458179] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
3 Bulow C, Langdon A, Hink T, Wallace M, Reske KA, Patel S, Sun X, Seiler S, Jones S, Kwon JH, Burnham CA, Dantas G, Dubberke ER. Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential. mSphere 2018;3:e00588-18. [PMID: 30463925 DOI: 10.1128/mSphereDirect.00588-18] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
4 Shogbesan O, Poudel DR, Victor S, Jehangir A, Fadahunsi O, Shogbesan G, Donato A. A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients. Can J Gastroenterol Hepatol 2018;2018:1394379. [PMID: 30246002 DOI: 10.1155/2018/1394379] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 13.3] [Reference Citation Analysis]
5 Merenstein D, El-Nachef N, Lynch SV. Fecal microbial therapy: promises and pitfalls. J Pediatr Gastroenterol Nutr 2014;59:157-61. [PMID: 24796803 DOI: 10.1097/MPG.0000000000000415] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
6 Konijeti GG, Sauk J, Shrime MG, Gupta M, Ananthakrishnan AN. Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis. Clin Infect Dis 2014;58:1507-14. [PMID: 24692533 DOI: 10.1093/cid/ciu128] [Cited by in Crossref: 100] [Cited by in F6Publishing: 96] [Article Influence: 12.5] [Reference Citation Analysis]
7 Ghimire S, Roy C, Wongkuna S, Antony L, Maji A, Keena MC, Foley A, Scaria J. Identification of Clostridioides difficile-Inhibiting Gut Commensals Using Culturomics, Phenotyping, and Combinatorial Community Assembly. mSystems 2020;5:e00620-19. [PMID: 32019832 DOI: 10.1128/mSystems.00620-19] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
8 Khoruts A, Hoffmann DE, Palumbo FB. The Impact of Regulatory Policies on the Future of Fecal Microbiota Transplantation. J Law Med Ethics 2019;47:482-504. [PMID: 31957587 DOI: 10.1177/1073110519897726] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
9 Tariq R, Saha S, Solanky D, Pardi DS, Khanna S. Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. J Clin Gastroenterol 2021;55:542-7. [PMID: 32701563 DOI: 10.1097/MCG.0000000000001398] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
10 Fuentes S, van Nood E, Tims S, Heikamp-de Jong I, ter Braak CJ, Keller JJ, Zoetendal EG, de Vos WM. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. ISME J. 2014;8:1621-1633. [PMID: 24577353 DOI: 10.1038/ismej.2014.13] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 15.6] [Reference Citation Analysis]
11 Stein RR, Bucci V, Toussaint NC, Buffie CG, Rätsch G, Pamer EG, Sander C, Xavier JB. Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiota. PLoS Comput Biol. 2013;9:e1003388. [PMID: 24348232 DOI: 10.1371/journal.pcbi.1003388] [Cited by in Crossref: 326] [Cited by in F6Publishing: 241] [Article Influence: 36.2] [Reference Citation Analysis]
12 Allegretti JR, Allegretti AS, Phelps E, Xu H, Kassam Z, Fischer M. Asymptomatic Clostridium difficile carriage rate post-fecal microbiota transplant is low: a prospective clinical and stool assessment. Clin Microbiol Infect 2018;24:780.e1-3. [PMID: 29104169 DOI: 10.1016/j.cmi.2017.10.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
13 Hooper MH, Kelly UM, Marik PE. An overview of the diagnosis and management of Clostridium difficile infection. Hosp Pract (1995) 2012;40:119-29. [PMID: 22406887 DOI: 10.3810/hp.2012.02.952] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Rogers AWL, Tsolis RM, Bäumler AJ. Salmonella versus the Microbiome. Microbiol Mol Biol Rev 2021;85:e00027-19. [PMID: 33361269 DOI: 10.1128/MMBR.00027-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
15 Byndloss MX, Litvak Y, Bäumler AJ. Microbiota-nourishing Immunity and Its Relevance for Ulcerative Colitis. Inflamm Bowel Dis 2019;25:811-5. [PMID: 30698700 DOI: 10.1093/ibd/izz004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
16 Nowland TL, Torok VA, Low WY, Plush KJ, Barton MD, Kirkwood RN. A Single Faecal Microbiota Transplantation Altered the Microbiota of Weaned Pigs. Life (Basel) 2020;10:E203. [PMID: 32942689 DOI: 10.3390/life10090203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Qi Z, Lyu M, Yang L, Yuan H, Cao Y, Zhai L, Dang W, Liu J, Yang F, Li Y. A Novel and Reliable Rat Model of Autism. Front Psychiatry 2021;12:549810. [PMID: 33776811 DOI: 10.3389/fpsyt.2021.549810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Verbeke F, Janssens Y, Wynendaele E, De Spiegeleer B. Faecal microbiota transplantation: a regulatory hurdle? BMC Gastroenterol 2017;17:128. [PMID: 29179687 DOI: 10.1186/s12876-017-0687-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
19 Lin YW, Montassier E, Knights D, Wei LN. Gut microbiota from metabolic disease-resistant, macrophage-specific RIP140 knockdown mice improves metabolic phenotype and gastrointestinal integrity. Sci Rep 2016;6:38599. [PMID: 27929078 DOI: 10.1038/srep38599] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
20 Ofosu A. Clostridium difficile infection: a review of current and emerging therapies. Ann Gastroenterol 2016;29:147-54. [PMID: 27065726 DOI: 10.20524/aog.2016.0006] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 10.2] [Reference Citation Analysis]
21 Feehan A, Garcia-Diaz J. Bacterial, Gut Microbiome-Modifying Therapies to Defend against Multidrug Resistant Organisms. Microorganisms 2020;8:E166. [PMID: 31991615 DOI: 10.3390/microorganisms8020166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Varier RU, Biltaji E, Smith KJ, Roberts MS, Jensen MK, LaFleur J, Nelson RE. Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection. Clin Microbiol Infect 2014;20:1343-51. [PMID: 25366338 DOI: 10.1111/1469-0691.12805] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
23 Gopalsamy SN, Sherman A, Woodworth MH, Lutgring JD, Kraft CS. Fecal Microbiota Transplant for Multidrug-Resistant Organism Decolonization Administered During Septic Shock. Infect Control Hosp Epidemiol 2018;39:490-2. [PMID: 29343312 DOI: 10.1017/ice.2017.300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Selber-Hnatiw S, Rukundo B, Ahmadi M, Akoubi H, Al-Bizri H, Aliu AF, Ambeaghen TU, Avetisyan L, Bahar I, Baird A, Begum F, Ben Soussan H, Blondeau-Éthier V, Bordaries R, Bramwell H, Briggs A, Bui R, Carnevale M, Chancharoen M, Chevassus T, Choi JH, Coulombe K, Couvrette F, D'Abreau S, Davies M, Desbiens MP, Di Maulo T, Di Paolo SA, Do Ponte S, Dos Santos Ribeiro P, Dubuc-Kanary LA, Duncan PK, Dupuis F, El-Nounou S, Eyangos CN, Ferguson NK, Flores-Chinchilla NR, Fotakis T, Gado Oumarou H D M, Georgiev M, Ghiassy S, Glibetic N, Grégoire Bouchard J, Hassan T, Huseen I, Ibuna Quilatan MF, Iozzo T, Islam S, Jaunky DB, Jeyasegaram A, Johnston MA, Kahler MR, Kaler K, Kamani C, Karimian Rad H, Konidis E, Konieczny F, Kurianowicz S, Lamothe P, Legros K, Leroux S, Li J, Lozano Rodriguez ME, Luponio-Yoffe S, Maalouf Y, Mantha J, McCormick M, Mondragon P, Narayana T, Neretin E, Nguyen TTT, Niu I, Nkemazem RB, O'Donovan M, Oueis M, Paquette S, Patel N, Pecsi E, Peters J, Pettorelli A, Poirier C, Pompa VR, Rajen H, Ralph RO, Rosales-Vasquez J, Rubinshtein D, Sakr S, Sebai MS, Serravalle L, Sidibe F, Sinnathurai A, Soho D, Sundarakrishnan A, Svistkova V, Ugbeye TE, Vasconcelos MS, Vincelli M, Voitovich O, Vrabel P, Wang L, Wasfi M, Zha CY, Gamberi C. Human Gut Microbiota: Toward an Ecology of Disease. Front Microbiol 2017;8:1265. [PMID: 28769880 DOI: 10.3389/fmicb.2017.01265] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 13.4] [Reference Citation Analysis]
25 Sartelli M, Pagani L, Iannazzo S, Moro ML, Viale P, Pan A, Ansaloni L, Coccolini F, D'Errico MM, Agreiter I, Amadio Nespola G, Barchiesi F, Benigni V, Binazzi R, Cappanera S, Chiodera A, Cola V, Corsi D, Cortese F, Crapis M, Cristini F, D'Arpino A, De Simone B, Di Bella S, Di Marzo F, Donati A, Elisei D, Fantoni M, Ferrari A, Foghetti D, Francisci D, Gattuso G, Giacometti A, Gesuelli GC, Marmorale C, Martini E, Meledandri M, Murri R, Padrini D, Palmieri D, Pauri P, Rebagliati C, Ricchizzi E, Sambri V, Schimizzi AM, Siquini W, Scoccia L, Scoppettuolo G, Sganga G, Storti N, Tavio M, Toccafondi G, Tumietto F, Viaggi B, Vivarelli M, Tranà C, Raso M, Labricciosa FM, Dhingra S, Catena F. A proposal for a comprehensive approach to infections across the surgical pathway. World J Emerg Surg 2020;15:13. [PMID: 32070390 DOI: 10.1186/s13017-020-00295-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
26 Leis S, Borody TJ, Jiang C, Campbell J. Fecal microbiota transplantation: A ‘How-To’ guide for nurses. Collegian 2015;22:445-51. [DOI: 10.1016/j.colegn.2014.08.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Moayyedi P, Marshall JK, Yuan Y, Hunt R. Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy. Can J Gastroenterol Hepatol 2014;28:66-8. [PMID: 25232572 DOI: 10.1155/2014/346590] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
28 Joseph J, Saha S, Greenberg-Worisek AJ. Fecal Microbiota Transplantation: An Ambiguous Translational Pathway for a Promising Treatment. Clin Transl Sci 2019;12:206-8. [PMID: 30861317 DOI: 10.1111/cts.12621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Shawhan R, Steele SR. Role of endoscopy in the assessment and treatment of Clostridium difficile infection. Seminars in Colon and Rectal Surgery 2014;25:128-33. [DOI: 10.1053/j.scrs.2014.05.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Chandra V, McAllister F. Therapeutic potential of microbial modulation in pancreatic cancer. Gut 2021:gutjnl-2019-319807. [PMID: 33906958 DOI: 10.1136/gutjnl-2019-319807] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Choy A, Freedberg DE. Impact of microbiome-based interventions on gastrointestinal pathogen colonization in the intensive care unit. Therap Adv Gastroenterol 2020;13:1756284820939447. [PMID: 32733601 DOI: 10.1177/1756284820939447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Vandenplas Y, Pierard D, De Greef E. Fecal Microbiota Transplantation: Just a Fancy Trend? J Pediatr Gastroenterol Nutr. 2015;61:4-7. [PMID: 25905546 DOI: 10.1097/mpg.0000000000000816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
33 Fischer M, Kao D, Mehta SR, Martin T, Dimitry J, Keshteli AH, Cook GK, Phelps E, Sipe BW, Xu H, Kelly CR. Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study. American Journal of Gastroenterology 2016;111:1024-31. [DOI: 10.1038/ajg.2016.180] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 12.2] [Reference Citation Analysis]
34 Wang JW, Wang YK, Zhang F, Su YC, Wang JY, Wu DC, Hsu WH. Initial experience of fecal microbiota transplantation in gastrointestinal disease: A case series. Kaohsiung J Med Sci. 2019;35:566-571. [PMID: 31197926 DOI: 10.1002/kjm2.12094] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
35 Liang J, Sha SM, Wu KC. Role of the intestinal microbiota and fecal transplantation in inflammatory bowel diseases. J Dig Dis 2014;15:641-6. [PMID: 25389085 DOI: 10.1111/1751-2980.12211] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
36 Weissman JS, Coyle W. Stool transplants: ready for prime time? Curr Gastroenterol Rep. 2012;14:313-316. [PMID: 22585070 DOI: 10.1007/s11894-012-0263-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
37 Kumar SB, Arnipalli SR, Ziouzenkova O. Antibiotics in Food Chain: The Consequences for Antibiotic Resistance. Antibiotics (Basel) 2020;9:E688. [PMID: 33066005 DOI: 10.3390/antibiotics9100688] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
38 Kump PK, Krause R, Allerberger F, Högenauer C. Faecal microbiota transplantation--the Austrian approach. Clin Microbiol Infect 2014;20:1106-11. [PMID: 25274251 DOI: 10.1111/1469-0691.12801] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
39 Berg AM, Kelly CP, Farraye FA. Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis 2013;19:194-204. [PMID: 22508484 DOI: 10.1002/ibd.22964] [Cited by in Crossref: 87] [Cited by in F6Publishing: 75] [Article Influence: 9.7] [Reference Citation Analysis]
40 Ojeda P, Bobe A, Dolan K, Leone V, Martinez K. Nutritional modulation of gut microbiota - the impact on metabolic disease pathophysiology. J Nutr Biochem 2016;28:191-200. [PMID: 26372091 DOI: 10.1016/j.jnutbio.2015.08.013] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
41 Parmar A. Gut-brain axis, psychobiotics, and mental health. Asian J Psychiatr 2016;22:84-5. [PMID: 27520903 DOI: 10.1016/j.ajp.2016.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
42 Martinez KB, Mackert JD, Mcintosh MK. Polyphenols and Intestinal Health. Nutrition and Functional Foods for Healthy Aging. Elsevier; 2017. pp. 191-210. [DOI: 10.1016/b978-0-12-805376-8.00018-6] [Cited by in Crossref: 12] [Article Influence: 2.4] [Reference Citation Analysis]
43 Kunde S, Pham A, Bonczyk S, Crumb T, Duba M, Conrad H Jr, Cloney D, Kugathasan S. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr. 2013;56:597-601. [PMID: 23542823 DOI: 10.1097/mpg.0b013e318292fa0d] [Cited by in Crossref: 191] [Cited by in F6Publishing: 106] [Article Influence: 23.9] [Reference Citation Analysis]
44 de Vos WM, de Vos EA. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr Rev. 2012;70 Suppl 1:S45-S56. [PMID: 22861807 DOI: 10.1111/j.1753-4887.2012.00505.x] [Cited by in Crossref: 245] [Cited by in F6Publishing: 216] [Article Influence: 24.5] [Reference Citation Analysis]
45 Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol. 2013;13:790-801. [PMID: 24096337 DOI: 10.1038/nri3535] [Cited by in Crossref: 738] [Cited by in F6Publishing: 654] [Article Influence: 82.0] [Reference Citation Analysis]
46 Kumagai H, Yokoyama K, Imagawa T, Inoue S, Tulyeu J, Tanaka M, Yamagata T. Failure of Fecal Microbiota Transplantation in a Three-Year-Old Child with Severe Refractory Ulcerative Colitis. Pediatr Gastroenterol Hepatol Nutr 2016;19:214-20. [PMID: 27738605 DOI: 10.5223/pghn.2016.19.3.214] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
47 Trueba AF, Ritz T, Trueba G. The Role of the Microbiome in the Relationship of Asthma and Affective Disorders. Adv Exp Med Biol 2016;874:263-88. [PMID: 26589224 DOI: 10.1007/978-3-319-20215-0_13] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
48 Yadav M, Chauhan NS. Microbiome therapeutics: exploring the present scenario and challenges. Gastroenterology Report 2021. [DOI: 10.1093/gastro/goab046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Mergenhagen KA, Wojciechowski AL, Paladino JA. A Review of the Economics of Treating Clostridium difficile Infection. PharmacoEconomics 2014;32:639-50. [DOI: 10.1007/s40273-014-0161-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
50 Fond G, Chevalier G, Eberl G, Leboyer M. [The potential role of microbiota in major psychiatric disorders: Mechanisms, preclinical data, gastro-intestinal comorbidities and therapeutic options]. Presse Med 2016;45:7-19. [PMID: 26653939 DOI: 10.1016/j.lpm.2015.10.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
51 Damman CJ, Miller SI, Surawicz CM, Zisman TL. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol 2012;107:1452-9. [PMID: 23034604 DOI: 10.1038/ajg.2012.93] [Cited by in Crossref: 135] [Cited by in F6Publishing: 120] [Article Influence: 13.5] [Reference Citation Analysis]
52 Batista R, Kapel N, Megerlin F, Chaumeil J, Barbut F, Bourlioux P, Chast F. Le transfert de microbiote fécal lors d’infections récidivantes à Clostridium difficile. Cadre et aspects pharmacotechniques. Annales Pharmaceutiques Françaises 2015;73:323-31. [DOI: 10.1016/j.pharma.2015.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
53 Staley C, Halaweish H, Graiziger C, Hamilton MJ, Kabage AJ, Galdys AL, Vaughn BP, Vantanasiri K, Suryanarayanan R, Sadowsky MJ, Khoruts A. Lower endoscopic delivery of freeze-dried intestinal microbiota results in more rapid and efficient engraftment than oral administration. Sci Rep 2021;11:4519. [PMID: 33633264 DOI: 10.1038/s41598-021-84152-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Cho S, Spencer E, Hirten R, Grinspan A, Dubinsky MC. Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 2019;68:343-7. [DOI: 10.1097/mpg.0000000000002172] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
55 Jackson M, Olefson S, Machan JT, Kelly CR. A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile Infection. J Clin Gastroenterol. 2016;50:742-746. [PMID: 26565971 DOI: 10.1097/mcg.0000000000000447] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
56 Sanders NL, Bollinger RR, Lee R, Thomas S, Parker W. Appendectomy and Clostridium difficile colitis: Relationships revealed by clinical observations and immunology. World J Gastroenterol 2013; 19(34): 5607-5614 [PMID: 24039352 DOI: 10.3748/wjg.v19.i34.5607] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
57 Wang X, Tsai T, Zuo B, Wei X, Deng F, Li Y, Maxwell CV, Yang H, Xiao Y, Zhao J. Donor age and body weight determine the effects of fecal microbiota transplantation on growth performance, and fecal microbiota development in recipient pigs. J Animal Sci Biotechnol 2022;13. [DOI: 10.1186/s40104-022-00696-1] [Reference Citation Analysis]
58 Kleger A, Schnell J, Essig A, Wagner M, Bommer M, Seufferlein T, Härter G. Fecal transplant in refractory Clostridium difficile colitis. Dtsch Arztebl Int. 2013;110:108-115. [PMID: 23468820 DOI: 10.3238/arztebl.2013.0108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
59 Wang Y, Zheng F, Liu S, Luo H. Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome. Gastroenterol Res Pract 2019;2019:9759138. [PMID: 31885549 DOI: 10.1155/2019/9759138] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
60 Hand TW. The Role of the Microbiota in Shaping Infectious Immunity. Trends Immunol 2016;37:647-58. [PMID: 27616558 DOI: 10.1016/j.it.2016.08.007] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 8.5] [Reference Citation Analysis]
61 Evrensel A, Ceylan ME. Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders. Clin Psychopharmacol Neurosci 2016;14:231-7. [PMID: 27489376 DOI: 10.9758/cpn.2016.14.3.231] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 11.8] [Reference Citation Analysis]
62 Almeida R, Gerbaba T, Petrof EO. Recurrent Clostridium difficile infection and the microbiome. J Gastroenterol 2016;51:1-10. [PMID: 26153514 DOI: 10.1007/s00535-015-1099-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
63 Hota SS, Surangiwala S, Paterson AS, Coburn B, Poutanen SM; Southern Ontario Fecal Microbiota Transplantation (SOFT) Movement*. Regional variability in fecal microbiota transplantation practices: a survey of the Southern Ontario Fecal Microbiota Transplantation Movement. CMAJ Open 2018;6:E184-90. [PMID: 29674329 DOI: 10.9778/cmajo.20170109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
64 Takáčová M, Bomba A, Tóthová C, Micháľová A, Turňa H. Any Future for Faecal Microbiota Transplantation as a Novel Strategy for Gut Microbiota Modulation in Human and Veterinary Medicine? Life 2022;12:723. [DOI: 10.3390/life12050723] [Reference Citation Analysis]
65 Ianiro G, Bibbò S, Scaldaferri F, Gasbarrini A, Cammarota G. Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement. Medicine (Baltimore) 2014;93:e97. [PMID: 25340496 DOI: 10.1097/MD.0000000000000097] [Cited by in Crossref: 54] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
66 Kim KO, Gluck M. Fecal Microbiota Transplantation: An Update on Clinical Practice. Clin Endosc. 2019;52:137-143. [PMID: 30909689 DOI: 10.5946/ce.2019.009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 15.7] [Reference Citation Analysis]
67 Shields K, Araujo-Castillo RV, Theethira TG, Alonso CD, Kelly CP. Recurrent Clostridium difficile infection: From colonization to cure. Anaerobe 2015;34:59-73. [PMID: 25930686 DOI: 10.1016/j.anaerobe.2015.04.012] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 7.7] [Reference Citation Analysis]
68 Postigo R, Kim JH. Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis. Infection 2012;40:643-8. [PMID: 22847629 DOI: 10.1007/s15010-012-0307-9] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
69 Waye A, Atkins K, Kao D. Cost Averted With Timely Fecal Microbiota Transplantation in the Management of Recurrent Clostridium difficile Infection in Alberta, Canada. J Clin Gastroenterol 2016;50:747-53. [PMID: 26890327 DOI: 10.1097/MCG.0000000000000494] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
70 Seekatz AM, Theriot CM, Rao K, Chang YM, Freeman AE, Kao JY, Young VB. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection. Anaerobe 2018;53:64-73. [PMID: 29654837 DOI: 10.1016/j.anaerobe.2018.04.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 17.8] [Reference Citation Analysis]
71 Jarrad AM, Karoli T, Blaskovich MA, Lyras D, Cooper MA. Clostridium difficile drug pipeline: challenges in discovery and development of new agents. J Med Chem. 2015;58:5164-5185. [PMID: 25760275 DOI: 10.1021/jm5016846] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 7.4] [Reference Citation Analysis]
72 Bowman KA, Broussard EK, Surawicz CM. Fecal microbiota transplantation: current clinical efficacy and future prospects. Clin Exp Gastroenterol. 2015;8:285-291. [PMID: 26566371 DOI: 10.2147/ceg.s61305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
73 Bakken JS. Staggered and tapered antibiotic withdrawal with administration of kefir for recurrent Clostridium difficile infection. Clin Infect Dis. 2014;59:858-861. [PMID: 24917658 DOI: 10.1093/cid/ciu429] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
74 Bornbusch SL, Harris RL, Grebe NM, Roche K, Dimac-Stohl K, Drea CM. Antibiotics and fecal transfaunation differentially affect microbiota recovery, associations, and antibiotic resistance in lemur guts. Anim Microbiome 2021;3:65. [PMID: 34598739 DOI: 10.1186/s42523-021-00126-z] [Reference Citation Analysis]
75 Pohl JF. Clostridium difficile infection and proton pump inhibitors. Current Opinion in Pediatrics 2012;24:627-31. [DOI: 10.1097/mop.0b013e328355a3e1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
76 Verwoerd A, Ter Haar NM, de Roock S, Vastert SJ, Bogaert D. The human microbiome and juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2016;14:55. [PMID: 27650128 DOI: 10.1186/s12969-016-0114-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
77 Mattner J, Schmidt F, Siegmund B. Faecal microbiota transplantation-A clinical view. Int J Med Microbiol 2016;306:310-5. [PMID: 26924753 DOI: 10.1016/j.ijmm.2016.02.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
78 Bouferraa Y, Chedid A, Amhaz G, El Lakkiss A, Mukherji D, Temraz S, Shamseddine A. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges. Int J Mol Sci 2021;22:8036. [PMID: 34360802 DOI: 10.3390/ijms22158036] [Reference Citation Analysis]
79 Zipursky JS, Sidorsky TI, Freedman CA, Sidorsky MN, Kirkland KB. Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection. Can J Gastroenterol Hepatol 2014;28:319-24. [PMID: 24719899 DOI: 10.1155/2014/403828] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
80 Hourigan SK, Chen LA, Grigoryan Z, Laroche G, Weidner M, Sears CL, Oliva-Hemker M. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease. Aliment Pharmacol Ther. 2015;42:741-752. [PMID: 26198180 DOI: 10.1111/apt.13326] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 6.9] [Reference Citation Analysis]
81 Keller JJ, Ooijevaar RE, Hvas CL, Terveer EM, Lieberknecht SC, Högenauer C, Arkkila P, Sokol H, Gridnyev O, Mégraud F, Kump PK, Nakov R, Goldenberg SD, Satokari R, Tkatch S, Sanguinetti M, Cammarota G, Dorofeev A, Gubska O, Laniro G, Mattila E, Arasaradnam RP, Sarin SK, Sood A, Putignani L, Alric L, Baunwall SMD, Kupcinskas J, Link A, Goorhuis AG, Verspaget HW, Ponsioen C, Hold GL, Tilg H, Kassam Z, Kuijper EJ, Gasbarrini A, Mulder CJJ, Williams HRT, Vehreschild MJGT. A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group. United European Gastroenterol J 2021;9:229-47. [PMID: 33151137 DOI: 10.1177/2050640620967898] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
82 Lex J. New drugs and devices from 2011 - 2012 that might change your practice. West J Emerg Med 2013;14:619-28. [PMID: 24381683 DOI: 10.5811/westjem.2013.2.16210] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
83 Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC, Brown EM, Schroeter K, Allen-Vercoe E. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome 2013;1:3. [PMID: 24467987 DOI: 10.1186/2049-2618-1-3] [Cited by in Crossref: 462] [Cited by in F6Publishing: 404] [Article Influence: 51.3] [Reference Citation Analysis]
84 Samuel BP, Crumb TL, Duba MM. What nurses need to know about fecal microbiota transplantation: education, assessment, and care for children and young adults. J Pediatr Nurs 2014;29:354-61. [PMID: 24582649 DOI: 10.1016/j.pedn.2014.01.013] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
85 Shankar V, Hamilton MJ, Khoruts A, Kilburn A, Unno T, Paliy O, Sadowsky MJ. Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation. Microbiome 2014;2:13. [PMID: 24855561 DOI: 10.1186/2049-2618-2-13] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 9.5] [Reference Citation Analysis]
86 Meehan AM, Tariq R, Khanna S. Challenges in management of recurrent and refractory Clostridium difficile infection. World J Clin Infect Dis 2016; 6(3): 28-36 [DOI: 10.5495/wjcid.v6.i3.28] [Reference Citation Analysis]
87 . European Obesity Summit (EOS) - Joint Congress of EASOand IFSO-EC, Gothenburg, Sweden, June 1 - 4, 2016: Abstracts. Obes Facts 2016;9 Suppl 1:1-376. [PMID: 27238363 DOI: 10.1159/000446744] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
88 Vigvári S, Sipos D, Solt J, Vincze Á, Kocsis B, Nemes Z, Kappéter Á, Feiszt Z, Kovács B, Péterfi Z. Faecal microbiota transplantation for Clostridium difficile infection using a lyophilized inoculum from non-related donors: A case series involving 19 patients. Acta Microbiol Immunol Hung 2019;66:69-78. [PMID: 29239198 DOI: 10.1556/030.64.2017.042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
89 De Leon LM, Watson JB, Kelly CR. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2013;11:1036-1038. [PMID: 23669309 DOI: 10.1016/j.cgh.2013.04.045] [Cited by in Crossref: 136] [Cited by in F6Publishing: 122] [Article Influence: 15.1] [Reference Citation Analysis]
90 Li M, Liang P, Li Z, Wang Y, Zhang G, Gao H, Wen S, Tang L. Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis. Front Microbiol. 2015;6:692. [PMID: 26217323 DOI: 10.3389/fmicb.2015.00692] [Cited by in Crossref: 35] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
91 Huang EY, Devkota S, Moscoso D, Chang EB, Leone VA. The role of diet in triggering human inflammatory disorders in the modern age. Microbes Infect. 2013;15:765-774. [PMID: 23876436 DOI: 10.1016/j.micinf.2013.07.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
92 Carmo J, Marques S, Chapim I, Túlio MA, Rodrigues JP, Bispo M, Chagas C. Leaping Forward in the Treatment of Clostridium Difficile Infection: Update in 2015. GE Port J Gastroenterol 2015;22:259-67. [PMID: 28868417 DOI: 10.1016/j.jpge.2015.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
93 Li S, Shao Y, Li K, Huangfu C, Wang W, Liu Z, Cai Z, Zhao B. Vascular Cognitive Impairment and the Gut Microbiota. JAD 2018;63:1209-22. [DOI: 10.3233/jad-171103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
94 Borody TJ, Peattie D, Mitchell SW. Fecal Microbiota Transplantation: Expanding Horizons for Clostridium difficile Infections and Beyond. Antibiotics (Basel). 2015;4:254-266. [PMID: 27025624 DOI: 10.3390/antibiotics4030254] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
95 Stripling J, Rodriguez M. Current Evidence in Delivery and Therapeutic Uses of Fecal Microbiota Transplantation in Human Diseases-Clostridium difficile Disease and Beyond. Am J Med Sci 2018;356:424-32. [PMID: 30384951 DOI: 10.1016/j.amjms.2018.08.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
96 Martin J, Mawer D, Wilcox MH. Clostridium difficile: biological therapies. Curr Opin Infect Dis 2013;26:454-60. [PMID: 23982236 DOI: 10.1097/01.qco.0000433319.82618.8f] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
97 Chen X, Huang YA, You ZH, Yan GY, Wang XS. A novel approach based on KATZ measure to predict associations of human microbiota with non-infectious diseases. Bioinformatics 2017;33:733-9. [PMID: 28025197 DOI: 10.1093/bioinformatics/btw715] [Cited by in Crossref: 36] [Cited by in F6Publishing: 53] [Article Influence: 7.2] [Reference Citation Analysis]
98 Schmidt EKA, Raposo PJF, Madsen KL, Fenrich KK, Kabarchuk G, Fouad K. What Makes a Successful Donor? Fecal Transplant from Anxious-Like Rats Does Not Prevent Spinal Cord Injury-Induced Dysbiosis. Biology (Basel) 2021;10:254. [PMID: 33804928 DOI: 10.3390/biology10040254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Houf J. Faecal microbiota transplants: towards a healthy disgust scepticism. Med Humanit 2021;47:407-16. [PMID: 34509994 DOI: 10.1136/medhum-2020-012135] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Hold GL, Smith M, Grange C, Watt ER, El-Omar EM, Mukhopadhya I. Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years? World J Gastroenterol 2014; 20(5): 1192-1210 [PMID: 24574795 DOI: 10.3748/wjg.v20.i5.1192] [Cited by in CrossRef: 209] [Cited by in F6Publishing: 190] [Article Influence: 26.1] [Reference Citation Analysis]
101 Kachrimanidou M, Sarmourli T, Skoura L, Metallidis S, Malisiovas N. Clostridium difficile infection: New insights into therapeutic options. Crit Rev Microbiol 2016;42:773-9. [PMID: 25955884 DOI: 10.3109/1040841X.2015.1027171] [Reference Citation Analysis]
102 El Hage R, Hernandez-Sanabria E, Van de Wiele T. Emerging Trends in "Smart Probiotics": Functional Consideration for the Development of Novel Health and Industrial Applications. Front Microbiol 2017;8:1889. [PMID: 29033923 DOI: 10.3389/fmicb.2017.01889] [Cited by in Crossref: 69] [Cited by in F6Publishing: 49] [Article Influence: 13.8] [Reference Citation Analysis]
103 DeFilipp Z, Hohmann E, Jenq RR, Chen YB. Fecal Microbiota Transplantation: Restoring the Injured Microbiome after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2019;25:e17-22. [PMID: 30408565 DOI: 10.1016/j.bbmt.2018.10.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
104 Kabeerdoss J, Sandhya P, Danda D. Gut inflammation and microbiome in spondyloarthritis. Rheumatol Int 2016;36:457-68. [PMID: 26719306 DOI: 10.1007/s00296-015-3414-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
105 Zhao C, Lv X, Fu J, He C, Hua H, Yan Z. In vitro inhibitory activity of probiotic products against oral Candida species. J Appl Microbiol 2016;121:254-62. [DOI: 10.1111/jam.13138] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
106 Bratburd JR, Arango RA, Horn HA. Defensive Symbioses in Social Insects Can Inform Human Health and Agriculture. Front Microbiol 2020;11:76. [PMID: 32117113 DOI: 10.3389/fmicb.2020.00076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
107 Żebrowska P, Łaczmańska I, Łaczmański Ł. Future Directions in Reducing Gastrointestinal Disorders in Children With ASD Using Fecal Microbiota Transplantation. Front Cell Infect Microbiol 2021;11:630052. [PMID: 33718277 DOI: 10.3389/fcimb.2021.630052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Davenport ER, Sanders JG, Song SJ, Amato KR, Clark AG, Knight R. The human microbiome in evolution. BMC Biol 2017;15:127. [PMID: 29282061 DOI: 10.1186/s12915-017-0454-7] [Cited by in Crossref: 104] [Cited by in F6Publishing: 87] [Article Influence: 20.8] [Reference Citation Analysis]
109 Suskind DL, Brittnacher MJ, Wahbeh G, Shaffer ML, Hayden HS, Qin X, Singh N, Damman CJ, Hager KR, Nielson H. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn’s disease. Inflamm Bowel Dis. 2015;21:556-563. [PMID: 25647155 DOI: 10.1097/mb.0000000000000307] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Malnick S, Melzer E. Human microbiome: From the bathroom to the bedside. World J Gastrointest Pathophysiol 2015; 6(3): 79-85 [PMID: 26301122 DOI: 10.4291/wjgp.v6.i3.79] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
111 Youngster I, Sauk J, Pindar C, Wilson RG, Kaplan JL, Smith MB, Alm EJ, Gevers D, Russell GH, Hohmann EL. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis. 2014;58:1515-1522. [PMID: 24762631 DOI: 10.1093/cid/ciu135] [Cited by in Crossref: 295] [Cited by in F6Publishing: 243] [Article Influence: 36.9] [Reference Citation Analysis]
112 Tariq R, Weatherly R, Kammer P, Pardi DS, Khanna S. Donor Screening Experience for Fecal Microbiota Transplantation in Patients With Recurrent C. difficile Infection. J Clin Gastroenterol 2018;52:146-50. [PMID: 27984397 DOI: 10.1097/MCG.0000000000000768] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 8.7] [Reference Citation Analysis]
113 Parnell JM, Nicholson MR, Kellermayer R, Kahn SA. Pediatric Fecal Microbiota Transplantation in Recurrent Clostridioides Difficile. Pediatr Ann 2021;50:e515-21. [PMID: 34889135 DOI: 10.3928/19382359-20211111-01] [Reference Citation Analysis]
114 Manthey C, Eckmann L, Fuhrmann V. Therapy for Clostridium difficile infection – any news beyond Metronidazole and Vancomycin? Expert Review of Clinical Pharmacology 2017;10:1239-50. [DOI: 10.1080/17512433.2017.1362978] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
115 Vindigni SM, Broussard EK, Surawicz CM. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond. Expert Review of Gastroenterology & Hepatology 2014;7:615-28. [DOI: 10.1586/17474124.2013.832501] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
116 Singh N, Haider NB. Microbiota, Microbiome, and Retinal Diseases. Int Ophthalmol Clin 2022;62:197-214. [PMID: 35325919 DOI: 10.1097/IIO.0000000000000418] [Reference Citation Analysis]
117 DuPont HL, Jiang ZD, DuPont AW, Utay NS. Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation. Dig Dis Sci 2020;65:741-56. [PMID: 32008133 DOI: 10.1007/s10620-020-06102-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
118 Martinez KB, Pierre JF, Chang EB. The Gut Microbiota: The Gateway to Improved Metabolism. Gastroenterol Clin North Am 2016;45:601-14. [PMID: 27837775 DOI: 10.1016/j.gtc.2016.07.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
119 Goldstein EJ, Citron DM, Claros MC, Tyrrell KL. Bacterial counts from five over-the-counter probiotics: are you getting what you paid for? Anaerobe 2014;25:1-4. [PMID: 24184290 DOI: 10.1016/j.anaerobe.2013.10.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
120 Nicco C, Paule A, Konturek P, Edeas M. From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation. Diseases 2020;8:E9. [PMID: 32326509 DOI: 10.3390/diseases8020009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
121 Clare-Pascoe N, Lee MG, Murphy T, Nicholson A, Ferguson TS. A Review of Clostridium difficile Infection at the University Hospital of the West Indies, Jamaica. West Indian Med J 2015;64:413-8. [PMID: 26624597 DOI: 10.7727/wimj.2014.180] [Reference Citation Analysis]
122 Winter G, Hart RA, Charlesworth RP, Sharpley CF. Gut microbiome and depression: what we know and what we need to know. Reviews in the Neurosciences 2018;29:629-43. [DOI: 10.1515/revneuro-2017-0072] [Cited by in Crossref: 95] [Cited by in F6Publishing: 79] [Article Influence: 23.8] [Reference Citation Analysis]
123 Leung PC, Cheng KF. Fecal microbiota transplantation: Historical review and current perspective. World J Meta-Anal 2019; 7(9): 423-427 [DOI: 10.13105/wjma.v7.i9.423] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
124 Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol. 2011;9:88-96. [PMID: 22183182 DOI: 10.1038/nrgastro.2011.244] [Cited by in Crossref: 367] [Cited by in F6Publishing: 333] [Article Influence: 33.4] [Reference Citation Analysis]
125 Petrof EO, Khoruts A. From stool transplants to next-generation microbiota therapeutics. Gastroenterology. 2014;146:1573-1582. [PMID: 24412527 DOI: 10.1053/j.gastro.2014.01.004] [Cited by in Crossref: 125] [Cited by in F6Publishing: 108] [Article Influence: 15.6] [Reference Citation Analysis]
126 König J, Siebenhaar A, Högenauer C, Arkkila P, Nieuwdorp M, Norén T, Ponsioen CY, Rosien U, Rossen NG, Satokari R, Stallmach A, de Vos W, Keller J, Brummer RJ. Consensus report: faecal microbiota transfer - clinical applications and procedures. Aliment Pharmacol Ther 2017;45:222-39. [PMID: 27891639 DOI: 10.1111/apt.13868] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 12.0] [Reference Citation Analysis]
127 Khoruts A, Staley C, Sadowsky MJ. Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology. Nat Rev Gastroenterol Hepatol 2021;18:67-80. [PMID: 32843743 DOI: 10.1038/s41575-020-0350-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
128 Weil AA, Hohmann EL. Fecal microbiota transplant: benefits and risks. Open Forum Infect Dis. 2015;2:ofv005. [PMID: 26034756 DOI: 10.1093/ofid/ofv005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
129 Razik R, Osman M, Lieberman A, Allegretti JR, Kassam Z. Faecal microbiota transplantation for <em>Clostridium difficile</em> infection: a multicentre study of non-responders. Med J Aust 2017;207:159-60. [PMID: 28814217 DOI: 10.5694/mja16.01452] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
130 Trifan A, Stoica O, Stanciu C, Cojocariu C, Singeap AM, Girleanu I, Miftode E. Clostridium difficile infection in patients with liver disease: a review. Eur J Clin Microbiol Infect Dis 2015;34:2313-24. [PMID: 26440041 DOI: 10.1007/s10096-015-2501-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
131 Allegretti JR, Kassam Z, Osman M, Budree S, Fischer M, Kelly CR. The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection. Gastrointest Endosc 2018;87:18-29. [PMID: 28583769 DOI: 10.1016/j.gie.2017.05.036] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
132 Moore T, Rodriguez A, Bakken JS. Fecal microbiota transplantation: a practical update for the infectious disease specialist. Clin Infect Dis. 2014;58:541-545. [PMID: 24368622 DOI: 10.1093/cid/cit950] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
133 Ekekezie C, Perler BK, Wexler A, Duff C, Lillis CJ, Kelly CR. Understanding the Scope of Do-It-Yourself Fecal Microbiota Transplant. Am J Gastroenterol 2020;115:603-7. [PMID: 31972620 DOI: 10.14309/ajg.0000000000000499] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
134 McCune VL, Quraishi MN, Manzoor S, Moran CE, Banavathi K, Steed H, Massey DCO, Trafford GR, Iqbal TH, Hawkey PM. Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment of Clostridioides difficile infection. EClinicalMedicine 2020;20:100301. [PMID: 32300746 DOI: 10.1016/j.eclinm.2020.100301] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
135 Geem D, Harusato A, Flannigan K, Denning TL. Harnessing regulatory T cells for the treatment of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1409-1418. [PMID: 25793328 DOI: 10.1097/mib.0000000000000343] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
136 Kates AE, Gaulke I, De Wolfe T, Zimbric M, Haight K, Watson L, Suen G, Kim K, Safdar N. Fecal microbiota transplantation for patients on antibiotic treatment with C. difficile infection history (GRAFT): Study protocol for a phase II, randomized, double-blind, placebo-controlled trial to prevent recurrent C. difficile infections. Contemp Clin Trials Commun 2020;18:100576. [PMID: 32518854 DOI: 10.1016/j.conctc.2020.100576] [Reference Citation Analysis]
137 Scott KP, Antoine JM, Midtvedt T, van Hemert S. Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis. 2015;26:25877. [PMID: 25651995 DOI: 10.3402/mehd.v26.25877] [Cited by in Crossref: 67] [Cited by in F6Publishing: 81] [Article Influence: 9.6] [Reference Citation Analysis]
138 Rosenfeld CS. Microbiome Disturbances and Autism Spectrum Disorders. Drug Metab Dispos 2015;43:1557-71. [PMID: 25852213 DOI: 10.1124/dmd.115.063826] [Cited by in Crossref: 125] [Cited by in F6Publishing: 108] [Article Influence: 17.9] [Reference Citation Analysis]
139 Shen Z, Zhu C, Quan Y, Yuan W, Wu S, Yang Z, Luo W, Tan B, Wang X. Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, clinical application, adverse reactions, and outlook. J Gastroenterol Hepatol. 2017;32:1804-1812. [PMID: 28677158 DOI: 10.1111/jgh.13861] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
140 Hamilton MJ, Weingarden AR, Unno T, Khoruts A, Sadowsky MJ. High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 2013;4:125-35. [PMID: 23333862 DOI: 10.4161/gmic.23571] [Cited by in Crossref: 206] [Cited by in F6Publishing: 190] [Article Influence: 22.9] [Reference Citation Analysis]
141 Wang S, Xu M, Wang W, Cao X, Piao M, Khan S, Yan F, Cao H, Wang B. Systematic Review: Adverse Events of Fecal Microbiota Transplantation. PLoS One. 2016;11:e0161174. [PMID: 27529553 DOI: 10.1371/journal.pone.0161174] [Cited by in Crossref: 163] [Cited by in F6Publishing: 145] [Article Influence: 27.2] [Reference Citation Analysis]
142 Jiang ZD, Ajami NJ, Petrosino JF, Jun G, Hanis CL, Shah M, Hochman L, Ankoma-Sey V, DuPont AW, Wong MC, Alexander A, Ke S, DuPont HL. Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy. Aliment Pharmacol Ther. 2017;45:899-908. [PMID: 28220514 DOI: 10.1111/apt.13969] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 20.4] [Reference Citation Analysis]
143 Paramsothy S, Borody TJ, Lin E, Finlayson S, Walsh AJ, Samuel D, van den Bogaerde J, Leong RWL, Connor S, Ng W, Mitchell HM, Kaakoush N, Kamm MA. Donor Recruitment for Fecal Microbiota Transplantation: . Inflammatory Bowel Diseases 2015;21:1600-6. [DOI: 10.1097/mib.0000000000000405] [Cited by in Crossref: 78] [Cited by in F6Publishing: 35] [Article Influence: 11.1] [Reference Citation Analysis]
144 Ma Y, Yang J, Cui B, Xu H, Xiao C, Zhang F. How Chinese clinicians face ethical and social challenges in fecal microbiota transplantation: a questionnaire study. BMC Med Ethics. 2017;18:39. [PMID: 28569156 DOI: 10.1186/s12910-017-0200-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
145 Karadsheh Z, Sule S. Fecal transplantation for the treatment of recurrent clostridium difficile infection. N Am J Med Sci. 2013;5:339-343. [PMID: 23923106 DOI: 10.4103/1947-2714.114163] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
146 Smith D, Jheeta S. Microbiome–Gut Dissociation: Investigating the Origins of Obesity. GastrointestDisord 2021;3:156-72. [DOI: 10.3390/gidisord3040017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
147 Jiménez-Avalos JA, Arrevillaga-Boni G, González-López L, García-Carvajal ZY, González-Avila M. Classical methods and perspectives for manipulating the human gut microbial ecosystem. Crit Rev Food Sci Nutr 2021;61:234-58. [PMID: 32114770 DOI: 10.1080/10408398.2020.1724075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
148 Nguyen TT, Kosciolek T, Eyler LT, Knight R, Jeste DV. Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder. J Psychiatr Res 2018;99:50-61. [PMID: 29407287 DOI: 10.1016/j.jpsychires.2018.01.013] [Cited by in Crossref: 91] [Cited by in F6Publishing: 71] [Article Influence: 22.8] [Reference Citation Analysis]
149 Hudson LE, Anderson SE, Corbett AH, Lamb TJ. Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev. 2017;30:191-231. [PMID: 27856521 DOI: 10.1128/cmr.00049-16] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 7.6] [Reference Citation Analysis]
150 Shen ZH, Zhu CX, Quan YS, Yang ZY, Wu S, Luo WW, Tan B, Wang XY. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation. World J Gastroenterol 2018; 24(1): 5-14 [PMID: 29358877 DOI: 10.3748/wjg.v24.i1.5] [Cited by in CrossRef: 145] [Cited by in F6Publishing: 116] [Article Influence: 36.3] [Reference Citation Analysis]
151 Alrabaa S, Jariwala R, Zeitler K, Montero J. Fecal microbiota transplantation outcomes in immunocompetent and immunocompromised patients: A single-center experience. Transpl Infect Dis 2017;19:e12726. [DOI: 10.1111/tid.12726] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
152 Norouzi-Beirami MH, Marashi SA, Banaei-Moghaddam AM, Kavousi K. Beyond Taxonomic Analysis of Microbiomes: A Functional Approach for Revisiting Microbiome Changes in Colorectal Cancer. Front Microbiol 2019;10:3117. [PMID: 32038558 DOI: 10.3389/fmicb.2019.03117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
153 Kelly BJ, Tebas P. Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection. Chest. 2018;153:266-277. [PMID: 28923757 DOI: 10.1016/j.chest.2017.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
154 Norin E. Experience with cultivated microbiota transplant: ongoing treatment of Clostridium difficile patients in Sweden. Microb Ecol Health Dis 2015;26:27638. [PMID: 26031676 DOI: 10.3402/mehd.v26.27638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
155 Terveer EM, van Beurden YH, Goorhuis A, Seegers JFML, Bauer MP, van Nood E, Dijkgraaf MGW, Mulder CJJ, Vandenbroucke-Grauls CMJE, Verspaget HW, Keller JJ, Kuijper EJ. How to: Establish and run a stool bank. Clin Microbiol Infect. 2017;23:924-930. [PMID: 28529025 DOI: 10.1016/j.cmi.2017.05.015] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 16.2] [Reference Citation Analysis]
156 Knight DR, Elliott B, Chang BJ, Perkins TT, Riley TV. Diversity and Evolution in the Genome of Clostridium difficile. Clin Microbiol Rev 2015;28:721-41. [PMID: 26085550 DOI: 10.1128/CMR.00127-14] [Cited by in Crossref: 146] [Cited by in F6Publishing: 84] [Article Influence: 20.9] [Reference Citation Analysis]
157 Manzoor SE, Zaman S, Whalley C, Inglis D, Bosworth A, Kidd M, Shabir S, Quraishi N, Green CA, Iqbal T, Beggs AD. Multi-modality detection of SARS-CoV-2 in faecal donor samples for transplantation and in asymptomatic emergency surgical admissions. F1000Res 2021;10:373. [PMID: 34367617 DOI: 10.12688/f1000research.52178.1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
158 Mondo E, Marliani G, Accorsi PA, Cocchi M, Di Leone A. Role of gut microbiota in dog and cat's health and diseases. Open Vet J 2019;9:253-8. [PMID: 31998619 DOI: 10.4314/ovj.v9i3.10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
159 Rogers GB, Bruce KD. Challenges and opportunities for faecal microbiota transplantation therapy. Epidemiol Infect 2013;141:2235-42. [PMID: 23735045 DOI: 10.1017/S0950268813001362] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
160 Canibe N, O'Dea M, Abraham S. Potential relevance of pig gut content transplantation for production and research. J Anim Sci Biotechnol 2019;10:55. [PMID: 31304012 DOI: 10.1186/s40104-019-0363-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
161 Yu S, Abdelkarim A, Nawras A, Hinch BT, Mbaso C, Valavoor S, Safi F, Hammersley J, Tang J, Assaly R. Fecal Transplant for Treatment of Toxic Megacolon Associated With Clostridium Difficile Colitis in a Patient With Duchenne Muscular Dystrophy. American Journal of Therapeutics 2016;23:e609-13. [DOI: 10.1097/mjt.0000000000000062] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
162 Collins SM, Kassam Z, Bercik P. The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol. 2013;16:240-245. [PMID: 23845749 DOI: 10.1016/j.mib.2013.06.004] [Cited by in Crossref: 121] [Cited by in F6Publishing: 112] [Article Influence: 13.4] [Reference Citation Analysis]
163 Chaparro-Rojas F, Mullane KM. Emerging therapies for Clostridium difficile infection - focus on fidaxomicin. Infect Drug Resist. 2013;6:41-53. [PMID: 23843696 DOI: 10.2147/idr.s24434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
164 Hutton ML, Pehlivanoglu H, Vidor CJ, James ML, Thomson MJ, Lyras D. Repurposing auranofin as a Clostridioides difficile therapeutic. J Antimicrob Chemother 2020;75:409-17. [PMID: 31642901 DOI: 10.1093/jac/dkz430] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
165 Kapel N, Thomas M, Corcos O, Mayeur C, Barbot-Trystram L, Bouhnik Y, Joly F. Practical implementation of faecal transplantation. Clin Microbiol Infect 2014;20:1098-105. [PMID: 25273614 DOI: 10.1111/1469-0691.12796] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
166 Sartelli M, Di Bella S, McFarland LV, Khanna S, Furuya-Kanamori L, Abuzeid N, Abu-Zidan FM, Ansaloni L, Augustin G, Bala M, Ben-Ishay O, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cortese F, Cui Y, Czepiel J, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckmann C, Eiland EH, Forrester JD, Fraga GP, Frossard JL, Fry DE, Galeiras R, Ghnnam W, Gomes CA, Griffiths EA, Guirao X, Ahmed MH, Herzog T, Kim JI, Iqbal T, Isik A, Itani KMF, Labricciosa FM, Lee YY, Juang P, Karamarkovic A, Kim PK, Kluger Y, Leppaniemi A, Lohsiriwat V, Machain GM, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Ordoñez CA, Pagani L, Petrosillo N, Portela F, Rasa K, Rems M, Sakakushev BE, Segovia-Lohse H, Sganga G, Shelat VG, Spigaglia P, Tattevin P, Tranà C, Urbánek L, Ulrych J, Viale P, Baiocchi GL, Catena F. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World J Emerg Surg 2019;14:8. [PMID: 30858872 DOI: 10.1186/s13017-019-0228-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 15.7] [Reference Citation Analysis]
167 Holster S, Lindqvist CM, Repsilber D, Salonen A, de Vos WM, König J, Brummer RJ. The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study. Clin Transl Gastroenterol 2019;10:e00034. [PMID: 31009405 DOI: 10.14309/ctg.0000000000000034] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
168 Bajaj JS, Khoruts A. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis. Journal of Hepatology 2020;72:1003-27. [DOI: 10.1016/j.jhep.2020.01.017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 17.0] [Reference Citation Analysis]
169 Mintz M, Khair S, Grewal S, LaComb JF, Park J, Channer B, Rajapakse R, Bucobo JC, Buscaglia JM, Monzur F, Chawla A, Yang J, Robertson CE, Frank DN, Li E. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis. PLoS One. 2018;13:e0190997. [PMID: 29385143 DOI: 10.1371/journal.pone.0190997] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
170 Wang LL, Janes ME, Kumbhojkar N, Kapate N, Clegg JR, Prakash S, Heavey MK, Zhao Z, Anselmo AC, Mitragotri S. Cell therapies in the clinic. Bioeng Transl Med 2021;6:e10214. [PMID: 34027097 DOI: 10.1002/btm2.10214] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
171 Cheng Y, Alhaffar D, Saha S, Khanna S, Bohm M, Phelps E, Ghabril M, Orman E, Sashidhar S, Rogers N, Xu H, Khoruts A, Vaughn B, Kao D, Wong K, Cammarota G, Ianiro G, Dhere T, Kraft CS, Mehta N, Woodworth MH, Allegretti JR, Nativ L, Marcus J, El-nachef N, Fischer M. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis. Clinical Gastroenterology and Hepatology 2021;19:1627-34. [DOI: 10.1016/j.cgh.2020.06.051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
172 Goyal H, Perisetti A, Rehman MR, Singla U. New and emerging therapies in treatment of Clostridium difficile infection. Eur J Gastroenterol Hepatol 2018;30:589-97. [PMID: 29521664 DOI: 10.1097/MEG.0000000000001103] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
173 Fond G, Boukouaci W, Chevalier G, Regnault A, Eberl G, Hamdani N, Dickerson F, Macgregor A, Boyer L, Dargel A. The “psychomicrobiotic”: Targeting microbiota in major psychiatric disorders: A systematic review. Pathol Biol (Paris). 2015;63:35-42. [PMID: 25468489 DOI: 10.1016/j.patbio.2014.10.003] [Cited by in Crossref: 109] [Cited by in F6Publishing: 92] [Article Influence: 13.6] [Reference Citation Analysis]
174 Midtvedt T, Norin E, Benno P, Dahlgren AL. Response to Surawicz et al. Am J Gastroenterol 2013;108:1931-2. [PMID: 24300869 DOI: 10.1038/ajg.2013.280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
175 Mantravadi PK, Kalesh KA, Dobson RCJ, Hudson AO, Parthasarathy A. The Quest for Novel Antimicrobial Compounds: Emerging Trends in Research, Development, and Technologies. Antibiotics (Basel) 2019;8:E8. [PMID: 30682820 DOI: 10.3390/antibiotics8010008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
176 Stanley JD, Bartlett JG, Dart BW 4th, Ashcraft JH. Clostridium difficile infection. Curr Probl Surg 2013;50:302-37. [PMID: 23764494 DOI: 10.1067/j.cpsurg.2013.02.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
177 Rao K, Young VB. Fecal microbiota transplantation for the management of Clostridium difficile infection. Infect Dis Clin North Am 2015;29:109-22. [PMID: 25677705 DOI: 10.1016/j.idc.2014.11.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
178 Dunn CM, Jeffries MA. The Microbiome in Osteoarthritis: a Narrative Review of Recent Human and Animal Model Literature. Curr Rheumatol Rep 2022. [PMID: 35389162 DOI: 10.1007/s11926-022-01066-6] [Reference Citation Analysis]
179 Tabbaa OM, Aboelsoud MM, Mattar MC. Long-Term Safety and Efficacy of Fecal Microbiota Transplantation in the Treatment of Clostridium difficile Infection in Patients With and Without Inflammatory Bowel Disease: A Tertiary Care Center's Experience. Gastroenterology Res 2018;11:397-403. [PMID: 30627262 DOI: 10.14740/gr1091] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
180 Zhang PP, Li LL, Han X, Li QW, Zhang XH, Liu JJ, Wang Y. Fecal microbiota transplantation improves metabolism and gut microbiome composition in db/db mice. Acta Pharmacol Sin 2020;41:678-85. [PMID: 31937933 DOI: 10.1038/s41401-019-0330-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
181 Kim M, Huda MN, Bennett BJ. Sequence Meets Function-Microbiota And Cardiovascular Disease. Cardiovasc Res 2021:cvab030. [PMID: 33537709 DOI: 10.1093/cvr/cvab030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Gilroy R. Spotlight on the avian gut microbiome: fresh opportunities in discovery. Avian Pathol 2021;:1-4. [PMID: 34264153 DOI: 10.1080/03079457.2021.1955826] [Reference Citation Analysis]
183 Suzuki K, Nakaoka S, Fukuda S, Masuya H. Energy landscape analysis elucidates the multistability of ecological communities across environmental gradients. Ecol Monogr 2021;91. [DOI: 10.1002/ecm.1469] [Reference Citation Analysis]
184 Yu Q, Jia A, Li Y, Bi Y, Liu G. Microbiota regulate the development and function of the immune cells. Int Rev Immunol 2018;37:79-89. [PMID: 29425062 DOI: 10.1080/08830185.2018.1429428] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
185 Sandhu BK, Edwards AN, Anderson SE, Woods EC, McBride SM. Regulation and Anaerobic Function of the Clostridioides difficile β-Lactamase. Antimicrob Agents Chemother 2019;64:e01496-19. [PMID: 31611350 DOI: 10.1128/AAC.01496-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
186 Hourigan SK, Ahn M, Gibson KM, Pérez-Losada M, Felix G, Weidner M, Leibowitz I, Niederhuber JE, Sears CL, Crandall KA, Oliva-Hemker M. Fecal Transplant in Children With Clostridioides difficile Gives Sustained Reduction in Antimicrobial Resistance and Potential Pathogen Burden. Open Forum Infect Dis 2019;6:ofz379. [PMID: 31660343 DOI: 10.1093/ofid/ofz379] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
187 Marra F, Ng K. Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection. Drugs 2015;75:1095-118. [PMID: 26113167 DOI: 10.1007/s40265-015-0422-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
188 Adamu BO, Lawley TD. Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection. Curr Opin Microbiol 2013;16:596-601. [PMID: 23866975 DOI: 10.1016/j.mib.2013.06.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
189 Wang J, Kuo C, Kuo F, Wang Y, Hsu W, Yu F, Hu H, Hsu P, Wang J, Wu D. Fecal microbiota transplantation: Review and update. Journal of the Formosan Medical Association 2019;118:S23-31. [DOI: 10.1016/j.jfma.2018.08.011] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 17.7] [Reference Citation Analysis]
190 Popa D, Neamtu B, Mihalache M, Boicean A, Banciu A, Banciu DD, Moga DFC, Birlutiu V. Fecal Microbiota Transplant in Severe and Non-Severe Clostridioides difficile Infection. Is There a Role of FMT in Primary Severe CDI? J Clin Med 2021;10:5822. [PMID: 34945118 DOI: 10.3390/jcm10245822] [Reference Citation Analysis]
191 O'Horo JC, Jindai K, Kunzer B, Safdar N. Treatment of recurrent Clostridium difficile infection: a systematic review. Infection 2014;42:43-59. [PMID: 23839210 DOI: 10.1007/s15010-013-0496-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
192 Messer JS, Liechty ER, Vogel OA, Chang EB. Evolutionary and ecological forces that shape the bacterial communities of the human gut. Mucosal Immunol 2017;10:567-79. [PMID: 28145439 DOI: 10.1038/mi.2016.138] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
193 Ott SJ, Waetzig GH, Rehman A, Moltzau-Anderson J, Bharti R, Grasis JA, Cassidy L, Tholey A, Fickenscher H, Seegert D, Rosenstiel P, Schreiber S. Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection. Gastroenterology. 2017;152:799-811.e7. [PMID: 27866880 DOI: 10.1053/j.gastro.2016.11.010] [Cited by in Crossref: 272] [Cited by in F6Publishing: 242] [Article Influence: 45.3] [Reference Citation Analysis]
194 Fischer M, Bittar M, Papa E, Kassam Z, Smith M. Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn's disease. Gut Microbes 2017;8:205-7. [PMID: 28103145 DOI: 10.1080/19490976.2017.1283469] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
195 Aktas B, Aslim B. Neuropathy in COVID-19 associated with dysbiosis-related inflammation. Turk J Biol 2021;45:390-403. [PMID: 34803442 DOI: 10.3906/biy-2105-53] [Reference Citation Analysis]
196 Rajeev R, Seethalakshmi PS, Jena PK, Prathiviraj R, Kiran GS, Selvin J. Gut microbiome responses in the metabolism of human dietary components: Implications in health and homeostasis. Crit Rev Food Sci Nutr 2021;:1-17. [PMID: 34016000 DOI: 10.1080/10408398.2021.1916429] [Reference Citation Analysis]
197 Rohlke F, Stollman N. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap Adv Gastroenterol. 2012;5:403-420. [PMID: 23152734 DOI: 10.1177/1756283x12453637] [Cited by in Crossref: 119] [Cited by in F6Publishing: 60] [Article Influence: 11.9] [Reference Citation Analysis]
198 Zainah H, Hassan M, Shiekh-Sroujieh L, Hassan S, Alangaden G, Ramesh M. Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection. Dig Dis Sci. 2015;60:181-185. [PMID: 25052150 DOI: 10.1007/s10620-014-3296-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
199 Haque SZ, Haque M. The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms - an appraisal. Clin Exp Gastroenterol 2017;10:91-103. [PMID: 28503071 DOI: 10.2147/CEG.S126243] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 4.4] [Reference Citation Analysis]
200 Owens C, Broussard E, Surawicz C. Fecal microbiota transplantation and donor standardization. Trends Microbiol. 2013;21:443-445. [PMID: 24012274 DOI: 10.1016/j.tim.2013.07.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
201 McSweeney B, Allegretti JR, Fischer M, Xu H, Goodman KJ, Monaghan T, McLeod C, Mullish BH, Petrof EO, Phelps EL, Chis R, Edmison A, Juby A, Ennis-Davis R, Roach B, Wong K, Kao D. In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation. Gut Microbes 2020;11:51-62. [PMID: 31122134 DOI: 10.1080/19490976.2019.1611153] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
202 Fareed S, Sarode N, Stewart FJ, Malik A, Laghaie E, Khizer S, Yan F, Pratte Z, Lewis J, Immergluck LC. Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children. PeerJ 2018;6:e4663. [PMID: 29868248 DOI: 10.7717/peerj.4663] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
203 Lin D, Koskella B. Friend and foe: factors influencing the movement of the bacterium Helicobacter pylori along the parasitism-mutualism continuum. Evol Appl. 2015;8:9-22. [PMID: 25667600 DOI: 10.1111/eva.12231] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
204 Mathur H, Rea MC, Cotter PD, Ross RP, Hill C. The potential for emerging therapeutic options for Clostridium difficile infection. Gut Microbes 2014;5:696-710. [PMID: 25564777 DOI: 10.4161/19490976.2014.983768] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
205 Vincent C, Manges AR. Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection. Antibiotics (Basel) 2015;4:230-53. [PMID: 27025623 DOI: 10.3390/antibiotics4030230] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
206 Chen J, Zaman A, Ramakrishna B, Olesen SW. Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank. Front Cell Infect Microbiol 2021;11:622949. [PMID: 33937092 DOI: 10.3389/fcimb.2021.622949] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
207 Scibelli N, Singh P, Raynor K. Intestinal Dysbiosis Disguised as a Rectal Fistula Treated With Autologous Fecal Microbiota Transplantation. Cureus 2021;13:e14115. [PMID: 33927926 DOI: 10.7759/cureus.14115] [Reference Citation Analysis]
208 Woodworth MH, Carpentieri C, Sitchenko KL, Kraft CS. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review. Gut Microbes. 2017;8:225-237. [PMID: 28129018 DOI: 10.1080/19490976.2017.1286006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
209 Schenck LP, Beck PL, MacDonald JA. Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection. World J Gastrointest Pathophysiol 2015; 6(4): 169-180 [PMID: 26600975 DOI: 10.4291/wjgp.v6.i4.169] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
210 Jin Song S, Woodhams DC, Martino C, Allaband C, Mu A, Javorschi-Miller-Montgomery S, Suchodolski JS, Knight R. Engineering the microbiome for animal health and conservation. Exp Biol Med (Maywood) 2019;244:494-504. [PMID: 30776908 DOI: 10.1177/1535370219830075] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 8.7] [Reference Citation Analysis]
211 Costello SP, Conlon MA, Vuaran MS, Roberts-Thomson IC, Andrews JM. Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: clinical efficacy and bacterial viability data. Aliment Pharmacol Ther. 2015;42:1011-1018. [PMID: 26264455 DOI: 10.1111/apt.13366] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 11.4] [Reference Citation Analysis]
212 Tikhonov M. Community-level cohesion without cooperation. Elife 2016;5:e15747. [PMID: 27310530 DOI: 10.7554/eLife.15747] [Cited by in Crossref: 52] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
213 Kates AE, Tischendorf JS, Schweizer M, Herwaldt L, Samore M, Dukes KC, Gerding DN, Diekema DJ, Safdar N. Research Agenda for Microbiome Based Research for Multidrug-resistant Organism Prevention in the Veterans Health Administration System. Infect Control Hosp Epidemiol 2018;39:202-9. [PMID: 29417924 DOI: 10.1017/ice.2017.311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
214 Raghu Subramanian C, Talluri S, Khan SU, Katz JA, Georgetson M, Sinh P. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Patients With Multiple Comorbidities: Long-Term Safety and Efficacy Results From a Tertiary Care Community Hospital. Gastroenterology Res 2020;13:138-45. [PMID: 32864024 DOI: 10.14740/gr1275] [Reference Citation Analysis]
215 Kumar M, Sarma DK, Shubham S, Kumawat M, Verma V, Nina PB, Jp D, Kumar S, Singh B, Tiwari RR. Futuristic Non-antibiotic Therapies to Combat Antibiotic Resistance: A Review. Front Microbiol 2021;12:609459. [PMID: 33574807 DOI: 10.3389/fmicb.2021.609459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
216 Tvede M, Tinggaard M, Helms M. Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000–2012. Clinical Microbiology and Infection 2015;21:48-53. [DOI: 10.1016/j.cmi.2014.07.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
217 Gomez-lavin J. Why expect causation at all? A pessimistic parallel with neuroscience. Biol Philos 2019;34. [DOI: 10.1007/s10539-019-9713-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
218 Sha S, Wu K. Letter: Faecal microbiota transplantation--not a one-size-fits-all approach; authors' reply. Aliment Pharmacol Ther 2014;40:119-20. [PMID: 24903434 DOI: 10.1111/apt.12801] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
219 Bluestone H, Kronman MP, Suskind DL. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients. J Pediatric Infect Dis Soc 2018;7:e6-8. [PMID: 29040661 DOI: 10.1093/jpids/pix076] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
220 Cammarota G, Ianiro G. Gut Microbiota and Cancer Patients: A Broad-Ranging Relationship. Mayo Clin Proc 2017;92:1605-7. [PMID: 29101928 DOI: 10.1016/j.mayocp.2017.09.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
221 Di Segni A, Braun T, BenShoshan M, Farage Barhom S, Glick Saar E, Cesarkas K, Squires JE, Keller N, Haberman Y. Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing. J Vis Exp 2018. [PMID: 29608151 DOI: 10.3791/56845] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
222 Andersen SB, Shapiro BJ, Vandenbroucke-Grauls C, de Vos MGJ. Microbial evolutionary medicine: from theory to clinical practice. Lancet Infect Dis 2019;19:e273-83. [PMID: 31053492 DOI: 10.1016/S1473-3099(19)30045-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
223 Albright MBN, Sevanto S, Gallegos-Graves V, Dunbar J. Biotic Interactions Are More Important than Propagule Pressure in Microbial Community Invasions. mBio 2020;11:e02089-20. [PMID: 33109758 DOI: 10.1128/mBio.02089-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
224 Knight CL, Surawicz CM. Clostridium difficile Infection. Medical Clinics of North America 2013;97:523-36. [DOI: 10.1016/j.mcna.2013.02.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
225 Rubin TA, Gessert CE, Aas J, Bakken JS. Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series. Anaerobe. 2013;19:22-26. [PMID: 23182843 DOI: 10.1016/j.anaerobe.2012.11.004] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 7.9] [Reference Citation Analysis]
226 Qin C, Zhang H, Zhao L, Zeng M, Huang W, Fu G, Zhou W, Wang H, Yan H. Microbiota transplantation reveals beneficial impact of berberine on hepatotoxicity by improving gut homeostasis. Sci China Life Sci 2018;61:1537-44. [DOI: 10.1007/s11427-017-9202-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
227 Kang Y, Cai Y. Gut microbiota and obesity: implications for fecal microbiota transplantation therapy. Hormones 2017;16:223-34. [DOI: 10.1007/bf03401517] [Cited by in Crossref: 20] [Article Influence: 4.0] [Reference Citation Analysis]
228 Paasché S. Fecal microbiota transplantation: an innovative approach to treating Clostridium difficile disease. JAAPA 2013;26:46-9. [PMID: 24049940 DOI: 10.1097/01.jaa.0000432570.98817.16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
229 Walton J, Burns D, Gaehle KE. Process and Outcome of Fecal Microbiota Transplants in Patients With Recurrent Clostridium difficile Infection: A Prospective Study. Gastroenterol Nurs 2017;40:411-9. [PMID: 28957971 DOI: 10.1097/SGA.0000000000000233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
230 Sood U, Bajaj A, Kumar R, Khurana S, Kalia VC. Infection and Microbiome: Impact of Tuberculosis on Human Gut Microbiome of Indian Cohort. Indian J Microbiol 2018;58:123-5. [PMID: 29434408 DOI: 10.1007/s12088-018-0706-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
231 Xiao Y, Angulo MT, Lao S, Weiss ST, Liu YY. An ecological framework to understand the efficacy of fecal microbiota transplantation. Nat Commun 2020;11:3329. [PMID: 32620839 DOI: 10.1038/s41467-020-17180-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
232 Perler BK, Chen B, Phelps E, Allegretti JR, Fischer M, Ganapini V, Krajiceck E, Kumar V, Marcus J, Nativ L, Kelly CR. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection. J Clin Gastroenterol. 2020;54:701-706. [PMID: 32011405 DOI: 10.1097/mcg.0000000000001281] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
233 Misch EA, Safdar N. Clostridioides difficile Infection in the Stem Cell Transplant and Hematologic Malignancy Population. Infect Dis Clin North Am 2019;33:447-66. [PMID: 31005136 DOI: 10.1016/j.idc.2019.02.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
234 Chintoan-Uta C, Wisedchanwet T, Glendinning L, Bremner A, Psifidi A, Vervelde L, Watson K, Watson M, Stevens MP. Role of Cecal Microbiota in the Differential Resistance of Inbred Chicken Lines to Colonization by Campylobacter jejuni. Appl Environ Microbiol 2020;86:e02607-19. [PMID: 31980428 DOI: 10.1128/AEM.02607-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
235 Nowland TL, Kirkwood RN. Faecal microbiota transplantation: is it the future for pig production? Microbiol Aust 2020;41:91. [DOI: 10.1071/ma20023] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
236 Bein A, Shin W, Jalili-Firoozinezhad S, Park MH, Sontheimer-Phelps A, Tovaglieri A, Chalkiadaki A, Kim HJ, Ingber DE. Microfluidic Organ-on-a-Chip Models of Human Intestine. Cell Mol Gastroenterol Hepatol. 2018;5:659-668. [PMID: 29713674 DOI: 10.1016/j.jcmgh.2017.12.010] [Cited by in Crossref: 218] [Cited by in F6Publishing: 189] [Article Influence: 54.5] [Reference Citation Analysis]
237 Hayes CS, Koskiniemi S, Ruhe ZC, Poole SJ, Low DA. Mechanisms and biological roles of contact-dependent growth inhibition systems. Cold Spring Harb Perspect Med 2014;4:a010025. [PMID: 24492845 DOI: 10.1101/cshperspect.a010025] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 7.4] [Reference Citation Analysis]
238 Kumar V, Fischer M. Expert opinion on fecal microbiota transplantation for the treatment of Clostridioides difficile infection and beyond. Expert Opin Biol Ther. 2020;20:73-81. [PMID: 31690143 DOI: 10.1080/14712598.2020.1689952] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
239 Kassam Z, Lee CH, Yuan Y, Hunt RH. Navigating long-term safety in fecal microbiota transplantation. Am J Gastroenterol. 2013;108:1538. [PMID: 24005359 DOI: 10.1038/ajg.2013.214] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
240 Langdon A, Crook N, Dantas G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med 2016;8:39. [PMID: 27074706 DOI: 10.1186/s13073-016-0294-z] [Cited by in Crossref: 394] [Cited by in F6Publishing: 328] [Article Influence: 65.7] [Reference Citation Analysis]
241 Suskind DL, Singh N, Nielson H, Wahbeh G. Fecal microbial transplant via nasogastric tube for active pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr. 2015;60:27-29. [PMID: 25162366 DOI: 10.1097/mpg.0000000000000544] [Cited by in Crossref: 63] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
242 Goldenberg SD, Batra R, Beales I, Digby-Bell JL, Irving PM, Kellingray L, Narbad A, Franslem-Elumogo N. Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review. Infect Dis Ther. 2018;7:71-86. [PMID: 29450831 DOI: 10.1007/s40121-018-0189-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
243 Raja TW, Veeramuthu D, Savarimuthu I, Al-Dhabi NA. Current Trends in the Treatment of Systemic Lupus Erythematosus. Curr Pharm Des 2020;26:2602-9. [PMID: 32066358 DOI: 10.2174/1381612826666200211122633] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
244 Bassett SA, Young W, Barnett MP, Cookson AL, McNabb WC, Roy NC. Changes in composition of caecal microbiota associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. Nutrients 2015;7:1798-816. [PMID: 25768951 DOI: 10.3390/nu7031798] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
245 Borody TJ, Campbell J. Fecal microbiota transplantation: techniques, applications, and issues. Gastroenterol Clin North Am. 2012;41:781-803. [PMID: 23101687 DOI: 10.1016/j.gtc.2012.08.008] [Cited by in Crossref: 87] [Cited by in F6Publishing: 74] [Article Influence: 9.7] [Reference Citation Analysis]
246 Krajicek E, Fischer M, Allegretti JR, Kelly CR. Nuts and Bolts of Fecal Microbiota Transplantation. Clin Gastroenterol Hepatol 2019;17:345-52. [PMID: 30268564 DOI: 10.1016/j.cgh.2018.09.029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
247 Alfawaz H, Al-Onazi M, Bukhari SI, Binobead M, Othman N, Algahtani N, Bhat RS, Moubayed NMS, Alzeer HS, El-Ansary A. The Independent and Combined Effects of Omega-3 and Vitamin B12 in Ameliorating Propionic Acid Induced Biochemical Features in Juvenile Rats as Rodent Model of Autism. J Mol Neurosci 2018;66:403-13. [PMID: 30284229 DOI: 10.1007/s12031-018-1186-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
248 Cohen I, Ruff WE, Longbrake EE. Influence of immunomodulatory drugs on the gut microbiota. Transl Res 2021;233:144-61. [PMID: 33515779 DOI: 10.1016/j.trsl.2021.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
249 Cui B, Li P, Xu L, Zhao Y, Wang H, Peng Z, Xu H, Xiang J, He Z, Zhang T, Nie Y, Wu K, Fan D, Ji G, Zhang F. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med. 2015;13:298. [PMID: 26363929 DOI: 10.1186/s12967-015-0646-2] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 11.6] [Reference Citation Analysis]
250 Matuchansky C. Fecal Microbiota Transplantation: The Case of Immunocompromised Patients. The American Journal of Medicine 2015;128:e21. [DOI: 10.1016/j.amjmed.2014.06.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
251 Pérez-Cobas AE, Moya A, Gosalbes MJ, Latorre A. Colonization Resistance of the Gut Microbiota against Clostridium difficile. Antibiotics (Basel) 2015;4:337-57. [PMID: 27025628 DOI: 10.3390/antibiotics4030337] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
252 Browne AS, Kelly CR. Fecal Transplant in Inflammatory Bowel Disease. Gastroenterol Clin North Am 2017;46:825-37. [PMID: 29173524 DOI: 10.1016/j.gtc.2017.08.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
253 Schroeder JL, Lunn M, Pinto AJ, Raskin L, Sloan WT. Probabilistic models to describe the dynamics of migrating microbial communities. PLoS One 2015;10:e0117221. [PMID: 25803866 DOI: 10.1371/journal.pone.0117221] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
254 Karasov TL, Almario J, Friedemann C, Ding W, Giolai M, Heavens D, Kersten S, Lundberg DS, Neumann M, Regalado J, Neher RA, Kemen E, Weigel D. Arabidopsis thaliana and Pseudomonas Pathogens Exhibit Stable Associations over Evolutionary Timescales. Cell Host Microbe 2018;24:168-179.e4. [PMID: 30001519 DOI: 10.1016/j.chom.2018.06.011] [Cited by in Crossref: 75] [Cited by in F6Publishing: 51] [Article Influence: 25.0] [Reference Citation Analysis]
255 Wertman JN, Dunn KA, Kulkarni K. The impact of the host intestinal microbiome on carcinogenesis and the response to chemotherapy. Future Oncol 2021;17:4371-87. [PMID: 34448411 DOI: 10.2217/fon-2021-0087] [Reference Citation Analysis]
256 Sbahi H, Di Palma JA. Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterol 2016;3:e000087. [PMID: 27239328 DOI: 10.1136/bmjgast-2016-000087] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
257 Bauer E, Thiele I. From Network Analysis to Functional Metabolic Modeling of the Human Gut Microbiota. mSystems 2018;3:e00209-17. [PMID: 29600286 DOI: 10.1128/mSystems.00209-17] [Cited by in Crossref: 50] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
258 Naclerio GA, Abutaleb NS, Li D, Seleem MN, Sintim HO. Ultrapotent Inhibitor of Clostridioides difficile Growth, Which Suppresses Recurrence In Vivo. J Med Chem 2020;63:11934-44. [PMID: 32960605 DOI: 10.1021/acs.jmedchem.0c01198] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
259 Sharma SM, Jackson D. Uveitis in the Spondyloarthopathies. Best Practice & Research Clinical Rheumatology 2017;31:846-62. [DOI: 10.1016/j.berh.2018.08.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 5.2] [Reference Citation Analysis]
260 Song Y, Garg S, Girotra M, Maddox C, von Rosenvinge EC, Dutta A, Dutta S, Fricke WF. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS One. 2013;8:e81330. [PMID: 24303043 DOI: 10.1371/journal.pone.0081330] [Cited by in Crossref: 125] [Cited by in F6Publishing: 107] [Article Influence: 13.9] [Reference Citation Analysis]
261 Harken AH. Carpet-bombing the colon is bad. J Thorac Cardiovasc Surg 2018;155:659. [PMID: 29102212 DOI: 10.1016/j.jtcvs.2017.09.117] [Reference Citation Analysis]
262 Urbaniak C, Burton JP, Reid G. Breast, milk and microbes: a complex relationship that does not end with lactation. Womens Health (Lond) 2012;8:385-98. [PMID: 22757730 DOI: 10.2217/whe.12.23] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
263 Hecker MT, Obrenovich ME, Cadnum JL, Jencson AL, Jain AK, Ho E, Donskey CJ. Fecal Microbiota Transplantation by Freeze-Dried Oral Capsules for Recurrent Clostridium difficile Infection. Open Forum Infect Dis 2016;3:ofw091. [PMID: 27822485 DOI: 10.1093/ofid/ofw091] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
264 . UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016;4:A157-720. [DOI: 10.1177/2050640616663689] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
265 Gupta S, Allen-Vercoe E, Petrof EO. Fecal microbiota transplantation: in perspective. Therap Adv Gastroenterol. 2016;9:229-239. [PMID: 26929784 DOI: 10.1177/1756283x15607414] [Cited by in Crossref: 142] [Cited by in F6Publishing: 70] [Article Influence: 23.7] [Reference Citation Analysis]
266 Di Bella S, Ascenzi P, Siarakas S, Petrosillo N, di Masi A. Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects. Toxins (Basel) 2016;8:E134. [PMID: 27153087 DOI: 10.3390/toxins8050134] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 13.3] [Reference Citation Analysis]
267 Tan P, Li X, Shen J, Feng Q. Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update. Front Pharmacol. 2020;11:574533. [PMID: 33041818 DOI: 10.3389/fphar.2020.574533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
268 Theuretzbacher U, Piddock LJ. Non-traditional Antibacterial Therapeutic Options and Challenges. Cell Host & Microbe 2019;26:61-72. [DOI: 10.1016/j.chom.2019.06.004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 19.0] [Reference Citation Analysis]
269 Brandt LJ, Aroniadis OC. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointest Endosc. 2013;78:240-249. [PMID: 23642791 DOI: 10.1016/j.gie.2013.03.1329] [Cited by in Crossref: 141] [Cited by in F6Publishing: 117] [Article Influence: 15.7] [Reference Citation Analysis]
270 Aroniadis OC, Brandt LJ, Greenberg A, Borody T, Kelly CR, Mellow M, Surawicz C, Cagle L, Neshatian L, Stollman N. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience. J Clin Gastroenterol. 2015;Epub ahead of print. [PMID: 26125460 DOI: 10.1097/mcg.0000000000000374] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
271 Zhang L, Zhan H, Xu W, Yan S, Ng SC. The role of gut mycobiome in health and diseases. Therap Adv Gastroenterol 2021;14:17562848211047130. [PMID: 34589139 DOI: 10.1177/17562848211047130] [Reference Citation Analysis]
272 Kassam Z, Lee CH, Hunt RH. Review of the Emerging Treatment of Clostridium difficile Infection with Fecal Microbiota Transplantation and Insights into Future Challenges. Clinics in Laboratory Medicine 2014;34:787-98. [DOI: 10.1016/j.cll.2014.08.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
273 Nowland TL, Torok VA, Low WY, Barton MD, Plush KJ, Kirkwood RN. Faecal Microbiota Analysis of Piglets During Lactation. Animals (Basel) 2020;10:E762. [PMID: 32349423 DOI: 10.3390/ani10050762] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
274 Seicean A, Moldovan-Pop A, Seicean R. Ulcerative colitis worsened after Clostridium difficile infection: Efficacy of infliximab. World J Gastroenterol 2014; 20(17): 5135-5140 [PMID: 24803831 DOI: 10.3748/wjg.v20.i17.5135] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
275 Michailidis L, Currier AC, Le M, Flomenhoft DR. Adverse events of fecal microbiota transplantation: a meta-analysis of high-quality studies. Ann Gastroenterol 2021;34:802-14. [PMID: 34815646 DOI: 10.20524/aog.2021.0655] [Reference Citation Analysis]
276 Redfern A, Suchodolski J, Jergens A. Role of the gastrointestinal microbiota in small animal health and disease. Vet Rec 2017;181:370. [PMID: 28916525 DOI: 10.1136/vr.103826] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
277 Cheng YW, Fischer M. The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly. Curr Treat Options Gastroenterol 2017;15:349-62. [PMID: 28748314 DOI: 10.1007/s11938-017-0143-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
278 Bono-lunn D, Villeneuve C, Abdulhay NJ, Harker M, Parker W. Policy and regulations in light of the human body as a ‘superorganism’ containing multiple, intertwined symbiotic relationships. Clinical Research and Regulatory Affairs 2016;33:39-48. [DOI: 10.1080/10601333.2016.1210159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
279 Opoku-Acheampong I, McLaud T, Anderson OS. Fecal Microbiota Transplantation to Prevent and Treat Chronic Disease: Implications for Dietetics Practice. J Acad Nutr Diet 2022;122:33-7. [PMID: 34487914 DOI: 10.1016/j.jand.2021.08.112] [Reference Citation Analysis]
280 Cheng W, Wang Z, Xiong Y, Wu Z, Tan X, Yang Y, Zhang H, Zhu X, Wei H, Tao S. N-(3-oxododecanoyl)-homoserine lactone disrupts intestinal barrier and induces systemic inflammation through perturbing gut microbiome in mice. Sci Total Environ 2021;778:146347. [PMID: 34030388 DOI: 10.1016/j.scitotenv.2021.146347] [Reference Citation Analysis]
281 Bokoliya SC, Dorsett Y, Panier H, Zhou Y. Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies. Front Cell Infect Microbiol 2021;11:711055. [PMID: 34621688 DOI: 10.3389/fcimb.2021.711055] [Reference Citation Analysis]
282 Kociolek LK, Gerding DN. Breakthroughs in the treatment and prevention of Clostridium difficile infection. Nat Rev Gastroenterol Hepatol. 2016;13:150-160. [PMID: 26860266 DOI: 10.1038/nrgastro.2015.220] [Cited by in Crossref: 82] [Cited by in F6Publishing: 73] [Article Influence: 13.7] [Reference Citation Analysis]
283 López-sanromán A, Rodríguez de Santiago E, Cobo Reinoso J, del Campo Moreno R, Foruny Olcina JR, García Fernández S, García García de Paredes A, Aguilera Castro L, Ferre Aracil C, Albillos Martínez A. Resultados de la implementación de un programa multidisciplinar de trasplante de microbiota fecal por colonoscopia para el tratamiento de la infección recurrente por Clostridium difficile. Gastroenterología y Hepatología 2017;40:605-14. [DOI: 10.1016/j.gastrohep.2017.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
284 Cammarota G, Ianiro G, Bibbò S, Gasbarrini A. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Intern Emerg Med. 2014;9:365-373. [PMID: 24664520 DOI: 10.1007/s11739-014-1069-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 7.9] [Reference Citation Analysis]
285 Jones JB, Liu L, Rank LA, Wetzel D, Woods EC, Biok N, Anderson SE, Lee MR, Liu R, Huth S, Sandhu BK, Gellman SH, McBride SM. Cationic Homopolymers Inhibit Spore and Vegetative Cell Growth of Clostridioides difficile. ACS Infect Dis 2021;7:1236-47. [PMID: 33739823 DOI: 10.1021/acsinfecdis.0c00843] [Reference Citation Analysis]
286 Kronman MP, Nielson HJ, Adler AL, Giefer MJ, Wahbeh G, Singh N, Zerr DM, Suskind DL. Fecal microbiota transplantation via nasogastric tube for recurrent clostridium difficile infection in pediatric patients. J Pediatr Gastroenterol Nutr. 2015;60:23-26. [PMID: 25162365 DOI: 10.1097/mpg.0000000000000545] [Cited by in Crossref: 49] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
287 Vujkovic-Cvijin I, Rutishauser RL, Pao M, Hunt PW, Lynch SV, McCune JM, Somsouk M. Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals. Gut Microbes 2017;8:440-50. [PMID: 28541799 DOI: 10.1080/19490976.2017.1334034] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
288 Khanna S, Pardi DS. Clostridium difficile infection: new insights into management. Mayo Clin Proc. 2012;87:1106-1117. [PMID: 23127735 DOI: 10.1016/j.mayocp.2012.07.016] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 9.1] [Reference Citation Analysis]
289 Khanna S, Pardi DS. Clostridium difficile infection: management strategies for a difficult disease. Therap Adv Gastroenterol 2014;7:72-86. [PMID: 24587820 DOI: 10.1177/1756283X13508519] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
290 Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, Adler K, Dick-Necula D, Raskin S, Bloch N, Rotin D, Anafi L, Avivi C, Melnichenko J, Steinberg-Silman Y, Mamtani R, Harati H, Asher N, Shapira-Frommer R, Brosh-Nissimov T, Eshet Y, Ben-Simon S, Ziv O, Khan MAW, Amit M, Ajami NJ, Barshack I, Schachter J, Wargo JA, Koren O, Markel G, Boursi B. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.Science. 2021;371:602-609. [PMID: 33303685 DOI: 10.1126/science.abb5920] [Cited by in Crossref: 73] [Cited by in F6Publishing: 78] [Article Influence: 36.5] [Reference Citation Analysis]
291 Vargason AM, Anselmo AC. Clinical translation of microbe-based therapies: Current clinical landscape and preclinical outlook. Bioeng Transl Med 2018;3:124-37. [PMID: 30065967 DOI: 10.1002/btm2.10093] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
292 Bubnov RV, Spivak MY, Lazarenko LM, Bomba A, Boyko NV. Probiotics and immunity: provisional role for personalized diets and disease prevention. EPMA J 2015;6:14. [PMID: 26221192 DOI: 10.1186/s13167-015-0036-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
293 Sadowsky MJ, Khoruts A. Faecal microbiota transplantation is promising but not a panacea. Nat Microbiol 2016;1:16015. [PMID: 27572174 DOI: 10.1038/nmicrobiol.2016.15] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
294 Vyas D, Aekka A, Vyas A. Fecal transplant policy and legislation. World J Gastroenterol 2015; 21(1): 6-11 [PMID: 25574076 DOI: 10.3748/wjg.v21.i1.6] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
295 Bakker GJ, Nieuwdorp M. Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond Clostridium difficile. Microbiol Spectr 2017;5. [PMID: 28840809 DOI: 10.1128/microbiolspec.BAD-0008-2017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
296 Smeuninx B, Boslem E, Febbraio MA. Current and Future Treatments in the Fight Against Non-Alcoholic Fatty Liver Disease. Cancers (Basel) 2020;12:E1714. [PMID: 32605253 DOI: 10.3390/cancers12071714] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
297 Shang Z, Chan SY, Song Q, Li P, Huang W. The Strategies of Pathogen-Oriented Therapy on Circumventing Antimicrobial Resistance. Research (Wash D C) 2020;2020:2016201. [PMID: 33083786 DOI: 10.34133/2020/2016201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
298 Kellermayer R. Prospects and challenges for intestinal microbiome therapy in pediatric gastrointestinal disorders. World J Gastrointest Pathophysiol 2013; 4(4): 91-93 [PMID: 24244876 DOI: 10.4291/wjgp.v4.i4.91] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
299 Damman CJ, Brittnacher MJ, Westerhoff M, Hayden HS, Radey M, Hager KR, Marquis SR, Miller SI, Zisman TL. Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis. PLoS One. 2015;10:e0133925. [PMID: 26288277 DOI: 10.1371/journal.pone.0133925] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
300 Choi HH, Cho YS. Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives. Clin Endosc. 2016;49:257-265. [PMID: 26956193 DOI: 10.5946/ce.2015.117] [Cited by in Crossref: 118] [Cited by in F6Publishing: 97] [Article Influence: 19.7] [Reference Citation Analysis]
301 Le P, Nghiem VT, Mullen PD, Deshpande A. Cost-Effectiveness of Competing Treatment Strategies for Clostridium difficile Infection: A Systematic Review. Infect Control Hosp Epidemiol 2018;39:412-24. [PMID: 29463339 DOI: 10.1017/ice.2017.303] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
302 McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66:e1-e48. [PMID: 29462280 DOI: 10.1093/cid/cix1085] [Cited by in Crossref: 718] [Cited by in F6Publishing: 613] [Article Influence: 239.3] [Reference Citation Analysis]
303 Gil F, Calderón IL, Fuentes JA, Paredes-Sabja D. Clostridioides (Clostridium) difficile infection: current and alternative therapeutic strategies. Future Microbiol 2018;13:469-82. [PMID: 29464969 DOI: 10.2217/fmb-2017-0203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
304 Terasaki M, Uehara O, Ogasa S, Sano T, Kubota A, Kojima H, Tanaka T, Maeda H, Miyashita K, Mutoh M. Alteration of fecal microbiota by fucoxanthin results in prevention of colorectal cancer in AOM/DSS mice. Carcinogenesis 2021;42:210-9. [PMID: 32940665 DOI: 10.1093/carcin/bgaa100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
305 Malnick SDH, Fisher D, Somin M, Neuman MG. Treating the Metabolic Syndrome by Fecal Transplantation-Current Status. Biology (Basel) 2021;10:447. [PMID: 34065241 DOI: 10.3390/biology10050447] [Reference Citation Analysis]
306 Chen WX, Ren LH, Shi RH. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis. World J Gastroenterol 2014; 20(42): 15657-15663 [PMID: 25400449 DOI: 10.3748/wjg.v20.i42.15657] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
307 Rao K, Safdar N. Fecal microbiota transplantation for the treatment of Clostridium difficile infection. J Hosp Med 2016;11:56-61. [PMID: 26344412 DOI: 10.1002/jhm.2449] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
308 Sageer M, Barto A. Recurrent Clostridium difficile infection: The scope of the problem and management decisions. Seminars in Colon and Rectal Surgery 2014;25:158-62. [DOI: 10.1053/j.scrs.2014.05.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
309 Liang D, Leung RK, Guan W, Au WW. Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities. Gut Pathog. 2018;10:3. [PMID: 29416567 DOI: 10.1186/s13099-018-0230-4] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 19.8] [Reference Citation Analysis]
310 Gibbons SM, Kearney SM, Smillie CS, Alm EJ. Two dynamic regimes in the human gut microbiome. PLoS Comput Biol 2017;13:e1005364. [PMID: 28222117 DOI: 10.1371/journal.pcbi.1005364] [Cited by in Crossref: 60] [Cited by in F6Publishing: 41] [Article Influence: 12.0] [Reference Citation Analysis]
311 Vargason AM, Santhosh S, Anselmo AC. Surface Modifications for Improved Delivery and Function of Therapeutic Bacteria. Small 2020;16:2001705. [DOI: 10.1002/smll.202001705] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
312 Avery L, Hasan M. Fecal Bacteriotherapy for Clostridium difficile Infections — Its Time Has Come. Clinical Microbiology Newsletter 2013;35:119-24. [DOI: 10.1016/j.clinmicnews.2013.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
313 Vigvári S, Vincze Á, Solt J, Sipos D, Feiszt Z, Kovács B, Kappéter Á, Péterfi Z. Experiences with fecal microbiota transplantation in Clostridium difficile infections via upper gastrointestinal tract. Acta Microbiol Immunol Hung 2019;66:179-88. [PMID: 30585500 DOI: 10.1556/030.65.2018.051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
314 Harnvoravongchai P, Chankhamhaengdecha S, Ounjai P, Singhakaew S, Boonthaworn K, Janvilisri T. Antimicrobial Effect of Asiatic Acid Against Clostridium difficile Is Associated With Disruption of Membrane Permeability. Front Microbiol 2018;9:2125. [PMID: 30245677 DOI: 10.3389/fmicb.2018.02125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
315 Mileto S, Das A, Lyras D, Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI. Enterotoxic Clostridia: Clostridioides difficile Infections. Microbiol Spectr 2019;7. [DOI: 10.1128/microbiolspec.gpp3-0015-2018] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
316 Hu YOO, Hugerth LW, Bengtsson C, Alisjahbana A, Seifert M, Kamal A, Sjöling Å, Midtvedt T, Norin E, Du J, Engstrand L. Bacteriophages Synergize with the Gut Microbial Community To Combat Salmonella. mSystems 2018;3:e00119-18. [PMID: 30320220 DOI: 10.1128/mSystems.00119-18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
317 Armstrong GD, Pillai DR, Louie TJ, Macdonald JA, Beck PL. A Potential New Tool for Managing Clostridium difficile Infection. Journal of Infectious Diseases 2013;207:1484-6. [DOI: 10.1093/infdis/jit069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
318 Saus E, Iraola-Guzmán S, Willis JR, Brunet-Vega A, Gabaldón T. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential. Mol Aspects Med 2019;69:93-106. [PMID: 31082399 DOI: 10.1016/j.mam.2019.05.001] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 22.3] [Reference Citation Analysis]
319 Lital Meyer S, Ricardo Espinoza A, Rodrigo Quera P. Infección por clostridium difficile: epidemiología, diagnóstico y estrategias terapéuticas. Revista Médica Clínica Las Condes 2014;25:473-84. [DOI: 10.1016/s0716-8640(14)70064-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
320 Hu J, Chen L, Tang Y, Xie C, Xu B, Shi M, Zheng W, Zhou S, Wang X, Liu L, Yan Y, Yang T, Niu Y, Hou Q, Xu X, Yan X. Standardized Preparation for Fecal Microbiota Transplantation in Pigs. Front Microbiol 2018;9:1328. [PMID: 29971061 DOI: 10.3389/fmicb.2018.01328] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
321 Brandt LJ. American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol. 2013;108:177-185. [PMID: 23318479 DOI: 10.1038/ajg.2012.450] [Cited by in Crossref: 119] [Cited by in F6Publishing: 99] [Article Influence: 13.2] [Reference Citation Analysis]
322 Barbut F, Collignon A, Butel MJ, Bourlioux P. [Fecal microbiota transplantation: review]. Ann Pharm Fr 2015;73:13-21. [PMID: 25577013 DOI: 10.1016/j.pharma.2014.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
323 Walker AW. The Human Microbiota and Pathogen Interactions. Molecular Medical Microbiology. Elsevier; 2015. pp. 347-56. [DOI: 10.1016/b978-0-12-397169-2.00019-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
324 Crow JR, Davis SL, Chaykosky DM, Smith TT, Smith JM. Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection. Pharmacotherapy 2015;35:1016-25. [PMID: 26598094 DOI: 10.1002/phar.1644] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
325 Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR, Muehlbauer MJ, Ilkayeva O, Semenkovich CF, Funai K, Hayashi DK, Lyle BJ, Martini MC, Ursell LK, Clemente JC, Van Treuren W, Walters WA, Knight R, Newgard CB, Heath AC, Gordon JI. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341:1241214. [PMID: 24009397 DOI: 10.1126/science.1241214] [Cited by in Crossref: 2021] [Cited by in F6Publishing: 1851] [Article Influence: 224.6] [Reference Citation Analysis]
326 Bass D, Stentiford GD, Wang HC, Koskella B, Tyler CR. The Pathobiome in Animal and Plant Diseases. Trends Ecol Evol 2019;34:996-1008. [PMID: 31522755 DOI: 10.1016/j.tree.2019.07.012] [Cited by in Crossref: 62] [Cited by in F6Publishing: 41] [Article Influence: 20.7] [Reference Citation Analysis]
327 Vaz NM, Carvalho CR. On the origin of immunopathology. J Theor Biol 2015;375:61-70. [PMID: 24937801 DOI: 10.1016/j.jtbi.2014.06.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
328 Yoon MY, Yoon SS. Disruption of the Gut Ecosystem by Antibiotics. Yonsei Med J 2018;59:4-12. [PMID: 29214770 DOI: 10.3349/ymj.2018.59.1.4] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 16.5] [Reference Citation Analysis]
329 Daliri EB, Tango CN, Lee BH, Oh D. Human microbiome restoration and safety. International Journal of Medical Microbiology 2018;308:487-97. [DOI: 10.1016/j.ijmm.2018.05.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
330 Quraishi MN, Widlak M, Bhala N, Moore D, Price M, Sharma N, Iqbal TH. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment Pharmacol Ther. 2017;46:479-493. [PMID: 28707337 DOI: 10.1111/apt.14201] [Cited by in Crossref: 234] [Cited by in F6Publishing: 199] [Article Influence: 46.8] [Reference Citation Analysis]
331 Torres J, Danese S, Colombel JF. New therapeutic avenues in ulcerative colitis: thinking out of the box. Gut. 2013;62:1642-1652. [PMID: 24104885 DOI: 10.1136/gutjnl-2012-303959] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
332 Leong KSW, Jayasinghe TN, Derraik JGB, Albert BB, Chiavaroli V, Svirskis DM, Beck KL, Conlon CA, Jiang Y, Schierding W, Vatanen T, Holland DJ, O'Sullivan JM, Cutfield WS. Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents. BMJ Open 2019;9:e026174. [PMID: 31005929 DOI: 10.1136/bmjopen-2018-026174] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
333 Radšel A, Andlovic A, Neubauer D, Osredkar D. Infant botulism: First two confirmed cases in Slovenia and literature review. European Journal of Paediatric Neurology 2013;17:651-6. [DOI: 10.1016/j.ejpn.2013.04.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
334 Sartelli M, Malangoni MA, Abu-Zidan FM, Griffiths EA, Di Bella S, McFarland LV, Eltringham I, Shelat VG, Velmahos GC, Kelly CP, Khanna S, Abdelsattar ZM, Alrahmani L, Ansaloni L, Augustin G, Bala M, Barbut F, Ben-Ishay O, Bhangu A, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Canterbury LA, Catena F, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cook CH, Cui Y, Czepiel J, Das K, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckert C, Eckmann C, Eiland EH, Enani MA, Faro M, Ferrada P, Forrester JD, Fraga GP, Frossard JL, Galeiras R, Ghnnam W, Gomes CA, Gorrepati V, Ahmed MH, Herzog T, Humphrey F, Kim JI, Isik A, Ivatury R, Lee YY, Juang P, Furuya-Kanamori L, Karamarkovic A, Kim PK, Kluger Y, Ko WC, LaBarbera FD, Lee JG, Leppaniemi A, Lohsiriwat V, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Nord CE, Ordoñez CA, Júnior GA, Petrosillo N, Portela F, Puri BK, Ray A, Raza M, Rems M, Sakakushev BE, Sganga G, Spigaglia P, Stewart DB, Tattevin P, Timsit JF, To KB, Tranà C, Uhl W, Urbánek L, van Goor H, Vassallo A, Zahar JR, Caproli E, Viale P. WSES guidelines for management of Clostridium difficile infection in surgical patients. World J Emerg Surg 2015;10:38. [PMID: 26300956 DOI: 10.1186/s13017-015-0033-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
335 Zama D, Bossù G, Leardini D, Muratore E, Biagi E, Prete A, Pession A, Masetti R. Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation. Ther Adv Hematol 2020;11:2040620719896961. [PMID: 32010434 DOI: 10.1177/2040620719896961] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
336 Tan KS, Lim RL, Liu J, Ong HH, Tan VJ, Lim HF, Chung KF, Adcock IM, Chow VT, Wang Y. Respiratory Viral Infections in Exacerbation of Chronic Airway Inflammatory Diseases: Novel Mechanisms and Insights From the Upper Airway Epithelium. Front Cell Dev Biol 2020;8:99. [PMID: 32161756 DOI: 10.3389/fcell.2020.00099] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
337 Nowland TL, Plush KJ, Barton M, Kirkwood RN. Development and Function of the Intestinal Microbiome and Potential Implications for Pig Production. Animals (Basel) 2019;9:E76. [PMID: 30823381 DOI: 10.3390/ani9030076] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
338 Chew SY, Than LT. Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches. Mycoses 2016;59:262-73. [PMID: 26765516 DOI: 10.1111/myc.12455] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
339 Zeitz J, Bissig M, Barthel C, Biedermann L, Scharl S, Pohl D, Frei P, Vavricka SR, Fried M, Rogler G, Scharl M. Patients' views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease? Eur J Gastroenterol Hepatol. 2017;29:322-330. [PMID: 27879485 DOI: 10.1097/meg.0000000000000783] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
340 Kassam Z, Murray TS. Navigating the Pediatric Microbiome: Emerging Evidence and Clinical Implications. Curr Pediatr Rep 2014;2:93-101. [DOI: 10.1007/s40124-014-0040-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
341 Terra DAA, Vilela EG, Silva ROS, LeÃo LA, Lima KS, Passos RIFÂ, Diniz AN, Coelho LGV. STRUCTURING A FECAL MICROBIOTA TRANSPLANTATION CENTER IN A UNIVERSITY HOSPITAL IN BRAZIL. Arq Gastroenterol 2020;57:434-58. [PMID: 33331486 DOI: 10.1590/S0004-2803.202000000-79] [Reference Citation Analysis]
342 Greub G. Culturomics: a new approach to study the human microbiome. Clinical Microbiology and Infection 2012;18:1157-9. [DOI: 10.1111/1469-0691.12032] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 6.6] [Reference Citation Analysis]
343 Zanella Terrier MC, Simonet ML, Bichard P, Frossard JL. Recurrent Clostridium difficile infections: The importance of the intestinal microbiota. World J Gastroenterol 2014; 20(23): 7416-7423 [PMID: 24966611 DOI: 10.3748/wjg.v20.i23.7416] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
344 Sha S, Liang J, Chen M, Xu B, Liang C, Wei N, Wu K. Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children. Aliment Pharmacol Ther. 2014;39:1003-1032. [PMID: 24641570 DOI: 10.1111/apt.12699] [Cited by in Crossref: 87] [Cited by in F6Publishing: 76] [Article Influence: 10.9] [Reference Citation Analysis]
345 Watson KM, Gaulke CA, Tsikitis VL. Understanding the microbiome: a primer on the role of the microbiome in colorectal neoplasia. Ann Gastroenterol 2020;33:223-36. [PMID: 32382225 DOI: 10.20524/aog.2020.0467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
346 Orenstein R, Griesbach CL, DiBaise JK. Moving fecal microbiota transplantation into the mainstream. Nutr Clin Pract 2013;28:589-98. [PMID: 23979974 DOI: 10.1177/0884533613497516] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
347 Church DL. Selected Topics in Anaerobic Bacteriology. Microbiol Spectr 2016;4. [PMID: 27726792 DOI: 10.1128/microbiolspec.DMIH2-0015-2015] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
348 Distrutti E, Monaldi L, Ricci P, Fiorucci S. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol 2016; 22(7): 2219-2241 [PMID: 26900286 DOI: 10.3748/wjg.v22.i7.2219] [Cited by in CrossRef: 155] [Cited by in F6Publishing: 120] [Article Influence: 25.8] [Reference Citation Analysis]
349 Borody TJ, Brandt LJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: a new standard treatment option for Clostridium difficile infection. Expert Rev Anti Infect Ther. 2013;11:447-449. [PMID: 23627849 DOI: 10.1586/eri.13.26] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
350 Fairhurst NG, Travis SPL. Why is it so difficult to evaluate faecal microbiota transplantation as a treatment for ulcerative colitis? Intest Res 2018;16:209-15. [PMID: 29743833 DOI: 10.5217/ir.2018.16.2.209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
351 Pouch SM, Friedman-Moraco RJ. Prevention and Treatment of Clostridium difficile-Associated Diarrhea in Solid Organ Transplant Recipients. Infect Dis Clin North Am 2018;32:733-48. [PMID: 30146033 DOI: 10.1016/j.idc.2018.05.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
352 Vrieze A, de Groot PF, Kootte RS, Knaapen M, van Nood E, Nieuwdorp M. Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease?Best Pract Res Clin Gastroenterol. 2013;27:127-137. [PMID: 23768558 DOI: 10.1016/j.bpg.2013.03.003] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
353 Suskind DL, Brittnacher MJ, Wahbeh G, Shaffer ML, Hayden HS, Qin X, Singh N, Damman CJ, Hager KR, Nielson H. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease. Inflamm Bowel Dis. 2015;21:556-563. [PMID: 25647155 DOI: 10.1097/mib.0000000000000307] [Cited by in Crossref: 132] [Cited by in F6Publishing: 77] [Article Influence: 18.9] [Reference Citation Analysis]
354 Yousefi B, Kokhaei P, Mehranfar F, Bahar A, Abdolshahi A, Emadi A, Eslami M. The role of the host microbiome in autism and neurodegenerative disorders and effect of epigenetic procedures in the brain functions. Neurosci Biobehav Rev 2021:S0149-7634(21)00488-7. [PMID: 34742725 DOI: 10.1016/j.neubiorev.2021.10.046] [Reference Citation Analysis]
355 Taur Y, Pamer EG. Microbiome mediation of infections in the cancer setting. Genome Med 2016;8:40. [PMID: 27090860 DOI: 10.1186/s13073-016-0306-z] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 7.7] [Reference Citation Analysis]
356 Pakyz AL, Moczygemba LR, VanderWielen LM, Edmond MB. Fecal microbiota transplantation for recurrent Clostridium difficile infection: The patient experience. Am J Infect Control 2016;44:554-9. [PMID: 26944009 DOI: 10.1016/j.ajic.2016.01.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
357 Khoruts A, Bajaj JS. Reply to: " 'You know my name, but not my story' - Deciding on an accurate nomenclature for faecal microbiota transplantation": Intestinal microbiota transplantation: Naming a new paradigm. J Hepatol 2020;72:1213-4. [PMID: 32197802 DOI: 10.1016/j.jhep.2020.02.014] [Reference Citation Analysis]
358 Menon R, Ramanan V, Korolev KS. Interactions between species introduce spurious associations in microbiome studies. PLoS Comput Biol 2018;14:e1005939. [PMID: 29338008 DOI: 10.1371/journal.pcbi.1005939] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
359 Belga S, Chiang D, Kabbani D, Abraldes JG, Cervera C. The direct and indirect effects of vancomycin-resistant enterococci colonization in liver transplant candidates and recipients. Expert Rev Anti Infect Ther 2019;17:363-73. [PMID: 30977692 DOI: 10.1080/14787210.2019.1607297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
360 Knežević D, Petković M. Faecal transplantation and Clostridioides difficile infection. Scripta Medica 2021;52:215-23. [DOI: 10.5937/scriptamed52-32752] [Reference Citation Analysis]
361 Cammarota G, Ianiro G, Kelly CR, Mullish BH, Allegretti JR, Kassam Z, Putignani L, Fischer M, Keller JJ, Costello SP, Sokol H, Kump P, Satokari R, Kahn SA, Kao D, Arkkila P, Kuijper EJ, Vehreschild MJG, Pintus C, Lopetuso L, Masucci L, Scaldaferri F, Terveer EM, Nieuwdorp M, López-Sanromán A, Kupcinskas J, Hart A, Tilg H, Gasbarrini A. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut 2019;68:2111-21. [PMID: 31563878 DOI: 10.1136/gutjnl-2019-319548] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 41.7] [Reference Citation Analysis]
362 Baral B, Mozafari MR. Strategic Moves of "Superbugs" Against Available Chemical Scaffolds: Signaling, Regulation, and Challenges. ACS Pharmacol Transl Sci 2020;3:373-400. [PMID: 32566906 DOI: 10.1021/acsptsci.0c00005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
363 Hota SS, Sales V, Tomlinson G, Salpeter MJ, Mcgeer A, Coburn B, Guttman DS, Low DE, Poutanen SM. Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial. Clinical Infectious Diseases 2017;64:265-71. [DOI: 10.1093/cid/ciw731] [Cited by in Crossref: 97] [Cited by in F6Publishing: 90] [Article Influence: 16.2] [Reference Citation Analysis]
364 Kim BS, Jeon YS, Chun J. Current status and future promise of the human microbiome. Pediatr Gastroenterol Hepatol Nutr. 2013;16:71-79. [PMID: 24010110 DOI: 10.5223/pghn.2013.16.2.71] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
365 Nagler CR. Drugging the microbiome. J Exp Med 2020;217:e20191642. [PMID: 32150223 DOI: 10.1084/jem.20191642] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
366 Hefazi M, Patnaik MM, Hogan WJ, Litzow MR, Pardi DS, Khanna S. Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospective Case Series. Mayo Clin Proc. 2017;92:1617-1624. [PMID: 29101931 DOI: 10.1016/j.mayocp.2017.08.016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
367 Jørgensen SMD, Hvas CL, Dahlerup JF, Mikkelsen S, Ehlers L, Hammeken LH, Licht TR, Bahl MI, Erikstrup C. Banking feces: a new frontier for public blood banks? Transfusion 2019;59:2776-82. [PMID: 31241182 DOI: 10.1111/trf.15422] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
368 Surawicz CM. Clostridium difficile infection: risk factors, diagnosis and management. Curr Treat Options Gastroenterol 2015;13:121-9. [PMID: 25567105 DOI: 10.1007/s11938-014-0038-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
369 Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol. 2014;48:693-702. [PMID: 24440934 DOI: 10.1097/mcg.0000000000000046] [Cited by in Crossref: 245] [Cited by in F6Publishing: 121] [Article Influence: 35.0] [Reference Citation Analysis]
370 Wong GC, Montgomery JM, Taylor MW. The Gut-Microbiota-Brain Axis in Autism Spectrum Disorder. In: Grabrucker AM, editor. Autism Spectrum Disorders. Exon Publications; 2021. pp. 95-114. [DOI: 10.36255/exonpublications.autismspectrumdisorders.2021.gutmicrobiota] [Reference Citation Analysis]
371 Goudarzi M, Seyedjavadi SS, Goudarzi H, Mehdizadeh Aghdam E, Nazeri S. Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options. Scientifica (Cairo) 2014;2014:916826. [PMID: 24991448 DOI: 10.1155/2014/916826] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
372 Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013;108:500-508. [PMID: 23511459 DOI: 10.1038/ajg.2013.59] [Cited by in Crossref: 553] [Cited by in F6Publishing: 479] [Article Influence: 61.4] [Reference Citation Analysis]
373 Lubomski M, Tan AH, Lim SY, Holmes AJ, Davis RL, Sue CM. Parkinson's disease and the gastrointestinal microbiome. J Neurol 2020;267:2507-23. [PMID: 31041582 DOI: 10.1007/s00415-019-09320-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 14.3] [Reference Citation Analysis]
374 Ettinger G, Burton JP, Reid G. If microbial ecosystem therapy can change your life, what's the problem? Bioessays 2013;35:508-12. [PMID: 23575749 DOI: 10.1002/bies.201300015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
375 Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108:478-98; quiz 499. [PMID: 23439232 DOI: 10.1038/ajg.2013.4] [Cited by in Crossref: 1051] [Cited by in F6Publishing: 862] [Article Influence: 116.8] [Reference Citation Analysis]
376 Jamrozik E, Selgelid MJ. Invisible epidemics: ethics and asymptomatic infection. Monash Bioeth Rev 2020;38:1-16. [PMID: 33326062 DOI: 10.1007/s40592-020-00123-z] [Reference Citation Analysis]
377 Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R, Sokol H, Arkkila P, Pintus C, Hart A, Segal J, Aloi M, Masucci L, Molinaro A, Scaldaferri F, Gasbarrini G, Lopez-Sanroman A, Link A, de Groot P, de Vos WM, Högenauer C, Malfertheiner P, Mattila E, Milosavljević T, Nieuwdorp M, Sanguinetti M, Simren M, Gasbarrini A; European FMT Working Group. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 2017;66:569-80. [PMID: 28087657 DOI: 10.1136/gutjnl-2016-313017] [Cited by in Crossref: 425] [Cited by in F6Publishing: 365] [Article Influence: 85.0] [Reference Citation Analysis]
378 Tashiro H, Shore SA. The Gut Microbiome and Ozone-induced Airway Hyperresponsiveness. Mechanisms and Therapeutic Prospects. Am J Respir Cell Mol Biol 2021;64:283-91. [PMID: 33091322 DOI: 10.1165/rcmb.2020-0288TR] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
379 Furuya-Kanamori L, Doi SA, Paterson DL, Helms SK, Yakob L, McKenzie SJ, Garborg K, Emanuelsson F, Stollman N, Kronman MP, Clark J, Huber CA, Riley TV, Clements AC. Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection: A Collaborative Analysis of Individual Patient Data From 14 Studies. J Clin Gastroenterol. 2017;51:145-150. [PMID: 26974758 DOI: 10.1097/mcg.0000000000000511] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
380 O'Brien S, Fothergill JL. The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung. FEMS Microbiol Lett 2017;364. [PMID: 28859314 DOI: 10.1093/femsle/fnx128] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 12.0] [Reference Citation Analysis]
381 Sun J, Chen YL, Ding YC, Zhong H, Wu M, Liu ZH, Ge LP. Deposition of resistant bacteria and resistome through FMT in germ-free piglets. Lett Appl Microbiol 2021;73:187-96. [PMID: 33894059 DOI: 10.1111/lam.13490] [Reference Citation Analysis]
382 Kim S, Park H, Song W, Jo S, Yang Y, Kim Y. LC–MS/MS based observation of Clostridium difficile inhibition by Lactobacillus rhamnosus GG. Journal of Industrial and Engineering Chemistry 2020;85:161-9. [DOI: 10.1016/j.jiec.2020.01.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
383 Li YT, Cai HF, Wang ZH, Xu J, Fang JY. Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection. Aliment Pharmacol Ther. 2016;43:445-457. [PMID: 26662643 DOI: 10.1111/apt.13492] [Cited by in Crossref: 92] [Cited by in F6Publishing: 75] [Article Influence: 13.1] [Reference Citation Analysis]
384 Tamma PD, Sandora TJ. Clostridium difficile Infection in Children: Current State and Unanswered Questions. J Pediatric Infect Dis Soc 2012;1:230-43. [PMID: 23687578 DOI: 10.1093/jpids/pis071] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
385 Allegretti JR, Kearney S, Li N, Bogart E, Bullock K, Gerber GK, Bry L, Clish CB, Alm E, Korzenik JR. Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles. Aliment Pharmacol Ther. 2016;43:1142-1153. [PMID: 27086647 DOI: 10.1111/apt.13616] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 14.0] [Reference Citation Analysis]
386 Villeneuve C, Kou HH, Eckermann H, Palkar A, Anderson LG, Mckenney EA, Bollinger RR, Parker W. Evolution of the hygiene hypothesis into biota alteration theory: what are the paradigms and where are the clinical applications? Microbes and Infection 2018;20:147-55. [DOI: 10.1016/j.micinf.2017.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
387 Panchal P, Budree S, Scheeler A, Medina G, Seng M, Wong WF, Eliott R, Mitchell T, Kassam Z, Allegretti JR, Osman M. Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future. Curr Gastroenterol Rep 2018;20. [DOI: 10.1007/s11894-018-0619-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
388 Nowland TL, Kirkwood RN, Pluske JR. Review: Can early-life establishment of the piglet intestinal microbiota influence production outcomes? Animal 2021;:100368. [PMID: 34649827 DOI: 10.1016/j.animal.2021.100368] [Reference Citation Analysis]
389 Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol. 2013;29:79-84. [PMID: 23041678 DOI: 10.1097/mog.0b013e32835a4b3e] [Cited by in Crossref: 201] [Cited by in F6Publishing: 112] [Article Influence: 22.3] [Reference Citation Analysis]
390 . Faecal microbiota transplantation. Drug Ther Bull 2014;52:141-4. [PMID: 25505015 DOI: 10.1136/dtb.2014.12.0298] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
391 Riaz Rajoka MS, Jin M, Haobin Z, Li Q, Shao D, Huang Q, Shi J. Impact of dietary compounds on cancer-related gut microbiota and microRNA. Appl Microbiol Biotechnol 2018;102:4291-303. [PMID: 29589094 DOI: 10.1007/s00253-018-8935-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
392 García-garcía-de-paredes A, Rodríguez-de-santiago E, Aguilera-castro L, Ferre-aracil C, López-sanromán A. Trasplante de microbiota fecal. Gastroenterología y Hepatología 2015;38:123-34. [DOI: 10.1016/j.gastrohep.2014.07.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
393 Mccune V, Struthers J, Hawkey P. Faecal transplantation for the treatment of Clostridium difficile infection: a review. International Journal of Antimicrobial Agents 2014;43:201-6. [DOI: 10.1016/j.ijantimicag.2013.10.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
394 Rode AA, Bytzer P, Pedersen OB, Engberg J. Establishing a donor stool bank for faecal microbiota transplantation: methods and feasibility. Eur J Clin Microbiol Infect Dis 2019;38:1837-47. [PMID: 31273647 DOI: 10.1007/s10096-019-03615-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
395 Guo WT, Dong LN, Wang JP, Liu P. New advances in clinical application of fecal microbiota transplantation. Shijie Huaren Xiaohua Zazhi 2014; 22(30): 4593-4598 [DOI: 10.11569/wcjd.v22.i30.4593] [Reference Citation Analysis]
396 Jayasinghe TN, Chiavaroli V, Holland DJ, Cutfield WS, O'Sullivan JM. The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation. Front Cell Infect Microbiol 2016;6:15. [PMID: 26925392 DOI: 10.3389/fcimb.2016.00015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
397 Brandt LJ. Fecal Microbiota Transplant: Respice, Adspice, Prospice. J Clin Gastroenterol. 2015;49 Suppl 1:S65-S68. [PMID: 26447968 DOI: 10.1097/mcg.0000000000000346] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
398 Luciano JA, Zuckerbraun BS. Clostridium difficile infection: prevention, treatment, and surgical management. Surg Clin North Am 2014;94:1335-49. [PMID: 25440127 DOI: 10.1016/j.suc.2014.08.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
399 Brandt LJ. Fecal Microbiota Therapy With a Focus on Clostridium difficile Infection. Psychosom Med 2017;79:868-73. [DOI: 10.1097/psy.0000000000000511] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
400 Jang MO, An JH, Jung SI, Park KH. Refractory Clostridium difficile Infection Cured With Fecal Microbiota Transplantation in Vancomycin-Resistant Enterococcus Colonized Patient. Intest Res 2015;13:80-4. [PMID: 25691847 DOI: 10.5217/ir.2015.13.1.80] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
401 Jørgensen SM, Hansen MM, Erikstrup C, Dahlerup JF, Hvas CL. Faecal microbiota transplantation: establishment of a clinical application framework. European Journal of Gastroenterology & Hepatology 2017;29:e36-45. [DOI: 10.1097/meg.0000000000000958] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
402 Drew GC, Stevens EJ, King KC. Microbial evolution and transitions along the parasite-mutualist continuum. Nat Rev Microbiol 2021. [PMID: 33875863 DOI: 10.1038/s41579-021-00550-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
403 Greenberg SA, Youngster I, Cohen NA, Livovsky DM, Strahilevitz J, Israeli E, Melzer E, Paz K, Fliss-Isakov N, Maharshak N. Five years of fecal microbiota transplantation - an update of the Israeli experience. World J Gastroenterol 2018; 24(47): 5403-5414 [PMID: 30598584 DOI: 10.3748/wjg.v24.i47.5403] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
404 Khoruts A. Fecal microbiota transplantation-early steps on a long journey ahead. Gut Microbes 2017;8:199-204. [PMID: 28394706 DOI: 10.1080/19490976.2017.1316447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
405 Lawley TD, Walker AW. Intestinal colonization resistance. Immunology. 2013;138:1-11. [PMID: 23240815 DOI: 10.1111/j.1365-2567.2012.03616.x] [Cited by in Crossref: 307] [Cited by in F6Publishing: 259] [Article Influence: 34.1] [Reference Citation Analysis]
406 Loenen WA. S-Adenosylmethionine Metabolism and Aging. Epigenetics of Aging and Longevity. Elsevier; 2018. pp. 59-93. [DOI: 10.1016/b978-0-12-811060-7.00003-6] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
407 Ávila PRM, Michels M, Vuolo F, Bilésimo R, Burger H, Milioli MVM, Sonai B, Borges H, Carneiro C, Abatti M, Santana IVV, Michelon C, Dal-pizzol F. Protective effects of fecal microbiota transplantation in sepsis are independent of the modulation of the intestinal flora. Nutrition 2020;73:110727. [DOI: 10.1016/j.nut.2020.110727] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
408 Litvak Y, Bäumler AJ. Microbiota-Nourishing Immunity: A Guide to Understanding Our Microbial Self. Immunity 2019;51:214-24. [DOI: 10.1016/j.immuni.2019.08.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
409 Carrière J, Darfeuille-Michaud A, Nguyen HTT. Infectious etiopathogenesis of Crohn’s disease. World J Gastroenterol 2014; 20(34): 12102-12117 [PMID: 25232246 DOI: 10.3748/wjg.v20.i34.12102] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
410 Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A, Aroniadis O, Barto A, Borody T, Giovanelli A, Gordon S, Gluck M, Hohmann EL, Kao D, Kao JY, McQuillen DP, Mellow M, Rank KM, Rao K, Ray A, Schwartz MA, Singh N, Stollman N, Suskind DL, Vindigni SM, Youngster I, Brandt L. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109:1065-1071. [PMID: 24890442 DOI: 10.1038/ajg.2014.133] [Cited by in Crossref: 378] [Cited by in F6Publishing: 338] [Article Influence: 47.3] [Reference Citation Analysis]
411 Culligan EP, Sleator RD. Advances in the Microbiome: Applications to Clostridium difficile Infection. J Clin Med 2016;5:E83. [PMID: 27657145 DOI: 10.3390/jcm5090083] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
412 Henig I, Yehudai-Ofir D, Zuckerman T. The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation. Haematologica 2021;106:933-46. [PMID: 33241674 DOI: 10.3324/haematol.2020.247395] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
413 Wei Y, Li N, Xing H, Guo T, Gong H, Chen D. Effectiveness of fecal microbiota transplantation for severe diarrhea after drug-induced hypersensitivity syndrome. Medicine (Baltimore) 2019;98:e18476. [PMID: 31876732 DOI: 10.1097/MD.0000000000018476] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
414 Hsu WH, Wang JY, Kuo CH. Current applications of fecal microbiota transplantation in intestinal disorders. Kaohsiung J Med Sci 2019;35:327-31. [PMID: 31017741 DOI: 10.1002/kjm2.12069] [Reference Citation Analysis]
415 Ianiro G, Maida M, Burisch J, Simonelli C, Hold G, Ventimiglia M, Gasbarrini A, Cammarota G. Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis. United European Gastroenterol J. 2018;6:1232-1244. [PMID: 30288286 DOI: 10.1177/2050640618780762] [Cited by in Crossref: 80] [Cited by in F6Publishing: 67] [Article Influence: 20.0] [Reference Citation Analysis]
416 Tariq R, Weatherly RM, Kammer PP, Pardi DS, Khanna S. Experience and Outcomes at a Specialized Clostridium difficile Clinical Practice. Mayo Clin Proc Innov Qual Outcomes 2017;1:49-56. [PMID: 30225401 DOI: 10.1016/j.mayocpiqo.2017.05.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
417 Steele SR, Mccormick J, Melton GB, Paquette I, Rivadeneira DE, Stewart D, Buie WD, Rafferty J. Practice Parameters for the Management of Clostridium difficile Infection. Diseases of the Colon & Rectum 2015;58:10-24. [DOI: 10.1097/dcr.0000000000000289] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
418 Wang J, Yang HR, Wang DJ, Wang XX. Association between the gut microbiota and patient responses to cancer immune checkpoint inhibitors. Oncol Lett 2020;20:342. [PMID: 33123253 DOI: 10.3892/ol.2020.12205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
419 Kim KO, Schwartz MA, Lin OST, Chiorean MV, Gluck M. Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection. Adv Ther 2019;36:2052-61. [PMID: 31154629 DOI: 10.1007/s12325-019-00974-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
420 Nandwana V, Debbarma S. Fecal Microbiota Transplantation: A Microbiome Modulation Technique for Alzheimer's Disease. Cureus 2021;13:e16503. [PMID: 34430117 DOI: 10.7759/cureus.16503] [Reference Citation Analysis]
421 Costello SP, Tucker EC, La Brooy J, Schoeman MN, Andrews JM. Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection. Clin Infect Dis 2016;62:908-14. [PMID: 26628567 DOI: 10.1093/cid/civ994] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 8.9] [Reference Citation Analysis]
422 Borgia G, Maraolo AE, Foggia M, Buonomo AR, Gentile I. Fecal microbiota transplantation for Clostridium difficile infection: back to the future. Expert Opin Biol Ther. 2015;15:1001-1014. [PMID: 26063385 DOI: 10.1517/14712598.2015.1045872] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
423 Emanuelsson F, Claesson BE, Ljungström L, Tvede M, Ung KA. Faecal microbiota transplantation and bacteriotherapy for recurrent Clostridium difficile infection: a retrospective evaluation of 31 patients. Scand J Infect Dis 2014;46:89-97. [PMID: 24354958 DOI: 10.3109/00365548.2013.858181] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
424 Pierog A, Mencin A, Reilly NR. Fecal microbiota transplantation in children with recurrent Clostridium difficile infection. Pediatr Infect Dis J. 2014;33:1198-1200. [PMID: 24853539 DOI: 10.1097/inf.0000000000000419] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
425 Khoruts A, Sadowsky MJ, Hamilton MJ. Development of fecal microbiota transplantation suitable for mainstream medicine. Clin Gastroenterol Hepatol 2015;13:246-50. [PMID: 25460566 DOI: 10.1016/j.cgh.2014.11.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
426 Sison-Mangus MP, Metzger CMJA, Ebert D. Host genotype-specific microbiota do not influence the susceptibility of D. magna to a bacterial pathogen. Sci Rep 2018;8:9407. [PMID: 29925845 DOI: 10.1038/s41598-018-27681-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
427 Tiffany CR, Bäumler AJ. Dysbiosis: from fiction to function. Am J Physiol Gastrointest Liver Physiol 2019;317:G602-8. [PMID: 31509433 DOI: 10.1152/ajpgi.00230.2019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
428 Dharmaratne P, Rahman N, Leung A, Ip M. Is there a role of faecal microbiota transplantation in reducing antibiotic resistance burden in gut? A systematic review and Meta-analysis. Ann Med 2021;53:662-81. [PMID: 34170204 DOI: 10.1080/07853890.2021.1927170] [Reference Citation Analysis]
429 Shin W, Hackley LA, Kim HJ. "Good Fences Make Good Neighbors": How does the Human Gut Microchip Unravel Mechanism of Intestinal Inflammation? Gut Microbes 2020;11:581-6. [PMID: 31198078 DOI: 10.1080/19490976.2019.1626684] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
430 Gardiner GE, Metzler-Zebeli BU, Lawlor PG. Impact of Intestinal Microbiota on Growth and Feed Efficiency in Pigs: A Review. Microorganisms 2020;8:E1886. [PMID: 33260665 DOI: 10.3390/microorganisms8121886] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
431 Khoruts A, Brandt LJ. Fecal Microbiota Transplant: A Rose by Any Other Name. Am J Gastroenterol 2019;114:1176-1176. [DOI: 10.14309/ajg.0000000000000286] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
432 Wang Y, Ren R, Sun G, Peng L, Tian Y, Yang Y. Pilot study of cytokine changes evaluation after fecal microbiota transplantation in patients with ulcerative colitis. Int Immunopharmacol 2020;85:106661. [PMID: 32563025 DOI: 10.1016/j.intimp.2020.106661] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
433 Wang Z, Hua W, Li C, Chang H, Liu R, Ni Y, Sun H, Li Y, Wang X, Hou M, Liu Y, Xu Z, Ji M. Protective Role of Fecal Microbiota Transplantation on Colitis and Colitis-Associated Colon Cancer in Mice Is Associated With Treg Cells. Front Microbiol 2019;10:2498. [PMID: 31798539 DOI: 10.3389/fmicb.2019.02498] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
434 Evrensel A, Ceylan ME. Fecal Microbiota Transplantation in the Treatment-Resistant Psychiatric Disorders. In: Kim Y, editor. Treatment Resistance in Psychiatry. Singapore: Springer; 2019. pp. 369-76. [DOI: 10.1007/978-981-10-4358-1_24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
435 Farooq PD, Urrunaga NH, Tang DM, von Rosenvinge EC. Pseudomembranous colitis. Dis Mon. 2015;61:181-206. [PMID: 25769243 DOI: 10.1016/j.disamonth.2015.01.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 5.9] [Reference Citation Analysis]
436 Tsolis RM, Bäumler AJ. Gastrointestinal host-pathogen interaction in the age of microbiome research. Curr Opin Microbiol 2020;53:78-89. [PMID: 32344325 DOI: 10.1016/j.mib.2020.03.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
437 Park H, Laffin MR, Jovel J, Millan B, Hyun JE, Hotte N, Kao D, Madsen KL. The success of fecal microbial transplantation in Clostridium difficile infection correlates with bacteriophage relative abundance in the donor: a retrospective cohort study. Gut Microbes 2019;10:676-87. [PMID: 30866714 DOI: 10.1080/19490976.2019.1586037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
438 Oakley BB, Buhr RJ, Ritz CW, Kiepper BH, Berrang ME, Seal BS, Cox NA. Successional changes in the chicken cecal microbiome during 42 days of growth are independent of organic acid feed additives. BMC Vet Res 2014;10:282. [PMID: 25427406 DOI: 10.1186/s12917-014-0282-8] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 9.8] [Reference Citation Analysis]
439 Khanna S, Pardi DS, Kelly CR, Kraft CS, Dhere T, Henn MR, Lombardo MJ, Vulic M, Ohsumi T, Winkler J, Pindar C, McGovern BH, Pomerantz RJ, Aunins JG, Cook DN, Hohmann EL. A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection. J Infect Dis. 2016;214:173-181. [PMID: 26908752 DOI: 10.1093/infdis/jiv766] [Cited by in Crossref: 202] [Cited by in F6Publishing: 170] [Article Influence: 33.7] [Reference Citation Analysis]
440 Martin LT, Vincent S, Gillian S, Moore K, Ratermann D, Droege CA. Pharmacologic Approach to Management of Clostridium difficile Infection. Crit Care Nurs Q 2019;42:2-11. [PMID: 30507659 DOI: 10.1097/CNQ.0000000000000232] [Reference Citation Analysis]
441 Fernández L, Ruiz L, Jara J, Orgaz B, Rodríguez JM. Strategies for the Preservation, Restoration and Modulation of the Human Milk Microbiota. Implications for Human Milk Banks and Neonatal Intensive Care Units. Front Microbiol 2018;9:2676. [PMID: 30473683 DOI: 10.3389/fmicb.2018.02676] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
442 Fischer M, Sipe BW, Rogers NA, Cook GK, Robb BW, Vuppalanchi R, Rex DK. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. Aliment Pharmacol Ther 2015;42:470-6. [PMID: 26096320 DOI: 10.1111/apt.13290] [Cited by in Crossref: 110] [Cited by in F6Publishing: 84] [Article Influence: 15.7] [Reference Citation Analysis]
443 Ma D, Chen Y, Chen T. Vaginal microbiota transplantation for the treatment of bacterial vaginosis: a conceptual analysis. FEMS Microbiology Letters 2019;366. [DOI: 10.1093/femsle/fnz025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
444 Chen C, Chen Y, Liou J, Wu M; for the Taiwan Gastrointestinal Disease and Helicobacter Consortium. From germ theory to germ therapy. Kaohsiung J Med Sci 2019;35:73-82. [DOI: 10.1002/kjm2.12011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
445 Sung J, Kim S, Cabatbat JJT, Jang S, Jin YS, Jung GY, Chia N, Kim PJ. Global metabolic interaction network of the human gut microbiota for context-specific community-scale analysis. Nat Commun 2017;8:15393. [PMID: 28585563 DOI: 10.1038/ncomms15393] [Cited by in Crossref: 100] [Cited by in F6Publishing: 86] [Article Influence: 20.0] [Reference Citation Analysis]
446 Woodworth MH, Neish EM, Miller NS, Dhere T, Burd EM, Carpentieri C, Sitchenko KL, Kraft CS. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. J Clin Microbiol. 2017;55:1002-1010. [PMID: 28077694 DOI: 10.1128/jcm.02327-16] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 6.6] [Reference Citation Analysis]
447 Vindigni SM, Surawicz CM. Fecal Microbiota Transplantation. Gastroenterol Clin North Am. 2017;46:171-185. [PMID: 28164849 DOI: 10.1016/j.gtc.2016.09.012] [Cited by in Crossref: 77] [Cited by in F6Publishing: 68] [Article Influence: 19.3] [Reference Citation Analysis]
448 Grandel NE, Reyes Gamas K, Bennett MR. Control of synthetic microbial consortia in time, space, and composition. Trends Microbiol 2021:S0966-842X(21)00096-2. [PMID: 33966922 DOI: 10.1016/j.tim.2021.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
449 Yan FY, Ju J, Gao F, Wang XQ. Application of fecal microbiota transplantation in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2015; 23(21): 3406-3412 [DOI: 10.11569/wcjd.v23.i21.3406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
450 de la Fuente-Nunez C, Torres MD, Mojica FJ, Lu TK. Next-generation precision antimicrobials: towards personalized treatment of infectious diseases. Curr Opin Microbiol 2017;37:95-102. [PMID: 28623720 DOI: 10.1016/j.mib.2017.05.014] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 12.2] [Reference Citation Analysis]
451 Gu X, Lu Q, Zhang C, Tang Z, Chu L. Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review. Semin Liver Dis 2021. [PMID: 34261137 DOI: 10.1055/s-0041-1732319] [Reference Citation Analysis]
452 Gaines S, Luo JN, Gilbert J, Zaborina O, Alverdy JC. Optimum Operating Room Environment for the Prevention of Surgical Site Infections. Surg Infect (Larchmt) 2017;18:503-7. [PMID: 28402706 DOI: 10.1089/sur.2017.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
453 Flannigan KL, Rajbar T, Moffat A, McKenzie LS, Dicke F, Rioux K, Workentine ML, Louie TJ, Hirota SA, Greenway SC. Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in a Pediatric Heart Transplant Patient. Front Cardiovasc Med 2017;4:17. [PMID: 28421185 DOI: 10.3389/fcvm.2017.00017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
454 Russell GH, Kaplan JL, Youngster I, Baril-Dore M, Schindelar L, Hohmann E, Winter HS. Fecal transplant for recurrent Clostridium difficile infection in children with and without inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014;58:588-592. [PMID: 24792627 DOI: 10.1097/mpg.0000000000000283] [Cited by in Crossref: 43] [Cited by in F6Publishing: 15] [Article Influence: 5.4] [Reference Citation Analysis]
455 Jones EW, Carlson JM. In silico analysis of antibiotic-induced Clostridium difficile infection: Remediation techniques and biological adaptations. PLoS Comput Biol 2018;14:e1006001. [PMID: 29451873 DOI: 10.1371/journal.pcbi.1006001] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
456 Enck K, Banks S, Yadav H, Welker ME, Opara EC. Development of a Novel Oral Delivery Vehicle for Probiotics. Curr Pharm Des 2020;26:3134-40. [PMID: 32039674 DOI: 10.2174/1381612826666200210111925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
457 Mullish BH, Marchesi JR, Thursz MR, Williams HR. Microbiome manipulation with faecal microbiome transplantation as a therapeutic strategy in Clostridium difficile infection. QJM 2015;108:355-9. [PMID: 25193538 DOI: 10.1093/qjmed/hcu182] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
458 Khoruts A, Sadowsky MJ. Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol. 2016;13:508-516. [PMID: 27329806 DOI: 10.1038/nrgastro.2016.98] [Cited by in Crossref: 207] [Cited by in F6Publishing: 189] [Article Influence: 34.5] [Reference Citation Analysis]
459 Kim YK, Shin C. The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments. Curr Neuropharmacol 2018;16:559-73. [PMID: 28925886 DOI: 10.2174/1570159X15666170915141036] [Cited by in Crossref: 60] [Cited by in F6Publishing: 27] [Article Influence: 15.0] [Reference Citation Analysis]
460 Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther. 2012;36:503-516. [PMID: 22827693 DOI: 10.1111/j.1365-2036.2012.05220.x] [Cited by in Crossref: 207] [Cited by in F6Publishing: 191] [Article Influence: 20.7] [Reference Citation Analysis]
461 Turroni F, Ventura M, Buttó LF, Duranti S, O'Toole PW, Motherway MO, van Sinderen D. Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci 2014;71:183-203. [PMID: 23516017 DOI: 10.1007/s00018-013-1318-0] [Cited by in Crossref: 163] [Cited by in F6Publishing: 149] [Article Influence: 18.1] [Reference Citation Analysis]
462 Bakken JS, Polgreen PM, Beekmann SE, Riedo FX, Streit JA. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians. Anaerobe 2013;24:20-4. [PMID: 24012687 DOI: 10.1016/j.anaerobe.2013.08.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
463 Vedantam G, Clark A, Chu M, McQuade R, Mallozzi M, Viswanathan VK. Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response. Gut Microbes. 2012;3:121-134. [PMID: 22555464 DOI: 10.4161/gmic.19399] [Cited by in Crossref: 121] [Cited by in F6Publishing: 115] [Article Influence: 12.1] [Reference Citation Analysis]
464 Davidovics ZH, Hyams JS. Fecal transplantation: re-discovering the value of stool. Current Opinion in Pediatrics 2013;25:618-23. [DOI: 10.1097/mop.0b013e328363ed66] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
465 Ding X, Yang X, Wang H. Methodology, efficacy and safety of fecal microbiota transplantation in treating inflammatory bowel disease. Medicine in Microecology 2020;6:100028. [DOI: 10.1016/j.medmic.2020.100028] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
466 Duarte-Chavez R, Wojda TR, Zanders TB, Geme B, Fioravanti G, Stawicki SP. Early Results of Fecal Microbial Transplantation Protocol Implementation at a Community-based University Hospital. J Glob Infect Dis 2018;10:47-57. [PMID: 29910564 DOI: 10.4103/jgid.jgid_145_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
467 Chen D, Wu J, Jin D, Wang B, Cao H. Fecal microbiota transplantation in cancer management: Current status and perspectives. Int J Cancer. 2018;. [PMID: 30458058 DOI: 10.1002/ijc.32003] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 15.0] [Reference Citation Analysis]
468 Mir S, Kellermayer R, Gulati AS. Pediatric Fecal Microbiota Transplantation. Curr Pediatr Rep 2014;2:227-34. [DOI: 10.1007/s40124-014-0049-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
469 Wang ZK, Yang YS, Chen Y, Yuan J, Sun G, Peng LH. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol 2014; 20(40): 14805-14820 [PMID: 25356041 DOI: 10.3748/wjg.v20.i40.14805] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
470 Rozas M, Hart de Ruijter A, Fabrega MJ, Zorgani A, Guell M, Paetzold B, Brillet F. From Dysbiosis to Healthy Skin: Major Contributions of Cutibacterium acnes to Skin Homeostasis. Microorganisms 2021;9:628. [PMID: 33803499 DOI: 10.3390/microorganisms9030628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
471 Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, Stollman N, Rohlke F, Surawicz C. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:1079-1087. [PMID: 22450732 DOI: 10.1038/ajg.2012.60] [Cited by in Crossref: 458] [Cited by in F6Publishing: 395] [Article Influence: 45.8] [Reference Citation Analysis]
472 Rapozo DCM, Bernardazzi C, de Souza HSP. Diet and microbiota in inflammatory bowel disease: The gut in disharmony. World J Gastroenterol 2017; 23(12): 2124-2140 [PMID: 28405140 DOI: 10.3748/wjg.v23.i12.2124] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 60] [Article Influence: 14.6] [Reference Citation Analysis]
473 Fischer M, Kao D, Kelly C, Kuchipudi A, Jafri SM, Blumenkehl M, Rex D, Mellow M, Kaur N, Sokol H. Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:2402-2409. [PMID: 27580384 DOI: 10.1097/mib.0000000000000908] [Cited by in Crossref: 88] [Cited by in F6Publishing: 49] [Article Influence: 22.0] [Reference Citation Analysis]
474 Smits LP, Bouter KE, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology. 2013;145:946-953. [PMID: 24018052 DOI: 10.1053/j.gastro.2013.08.058] [Cited by in Crossref: 350] [Cited by in F6Publishing: 304] [Article Influence: 38.9] [Reference Citation Analysis]
475 Agarwal A, Maheshwari A, Verma S, Arrup D, Phillips L, Vinayek R, Nair P, Hagan M, Dutta S. Superiority of Higher-Volume Fresh Feces Compared to Lower-Volume Frozen Feces in Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Colitis. Dig Dis Sci 2021;66:2000-4. [PMID: 32656604 DOI: 10.1007/s10620-020-06459-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
476 Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore D, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Williams HR, Goldenberg SD. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. J Hosp Infect. 2018;100 Suppl 1:S1-S31. [PMID: 30173851 DOI: 10.1016/j.jhin.2018.07.037] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
477 Allen-Vercoe E, Petrof EO. Artificial stool transplantation: progress towards a safer, more effective and acceptable alternative. Expert Rev Gastroenterol Hepatol 2013;7:291-3. [PMID: 23639085 DOI: 10.1586/egh.13.16] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
478 Brusaferro A, Cavalli E, Farinelli E, Cozzali R, Principi N, Esposito S. Gut dysbiosis and paediatric Crohn's disease. J Infect 2019;78:1-7. [PMID: 30336176 DOI: 10.1016/j.jinf.2018.10.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
479 Woodworth MH, Kraft CS, Meredith EJ, Mehta AK, Wang T, Mamo YT, Dhere T, Sitchenko KL, Patzer RE, Friedman-Moraco RJ. Tacrolimus concentration to dose ratio in solid organ transplant patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. Transpl Infect Dis 2018;20:e12857. [PMID: 29446866 DOI: 10.1111/tid.12857] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
480 Turse EP, Dailey FE, Ghouri YA, Tahan V. Fecal microbiota transplantation donation: the gift that keeps on giving. Curr Opin Pharmacol. 2019;49:24-28. [PMID: 31085417 DOI: 10.1016/j.coph.2019.04.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
481 Comito D, Cascio A, Romano C. Microbiota biodiversity in inflammatory bowel disease. Ital J Pediatr 2014;40:32. [PMID: 24684926 DOI: 10.1186/1824-7288-40-32] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
482 Sobol S, Baker A, Konrad R, Miniard J. Fecal Microbiota Transplant: Could Your Stool Save a Life? The Journal for Nurse Practitioners 2015;11:878-82. [DOI: 10.1016/j.nurpra.2015.07.012] [Reference Citation Analysis]
483 Di Bella S, Drapeau C, García-Almodóvar E, Petrosillo N. Fecal microbiota transplantation: the state of the art. Infect Dis Rep. 2013;5:e13. [PMID: 24470963 DOI: 10.4081/idr.2013.e13] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
484 Tan X, Johnson S. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'. Anaerobe 2019;60:102092. [PMID: 31472233 DOI: 10.1016/j.anaerobe.2019.102092] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
485 Pathak R, Enuh HA, Patel A, Wickremesinghe P. Treatment of relapsing Clostridium difficile infection using fecal microbiota transplantation. Clin Exp Gastroenterol. 2013;7:1-6. [PMID: 24421645 DOI: 10.2147/ceg.s53410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 0.1] [Reference Citation Analysis]
486 Taur Y, Pamer EG. The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis 2013;26:332-7. [PMID: 23806896 DOI: 10.1097/QCO.0b013e3283630dd3] [Cited by in Crossref: 83] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
487 Ünal CM, Steinert M. Novel therapeutic strategies for Clostridium difficile infections. Expert Opin Ther Targets 2016;20:269-85. [PMID: 26565670 DOI: 10.1517/14728222.2016.1090428] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
488 Dehlholm-Lambertsen E, Hall BK, Jørgensen SMD, Jørgensen CW, Jensen ME, Larsen S, Jensen JS, Ehlers L, Dahlerup JF, Hvas CL. Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection. Therap Adv Gastroenterol 2019;12:1756284819843002. [PMID: 31007720 DOI: 10.1177/1756284819843002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
489 Lei C, Mu J, Teng Y, He L, Xu F, Zhang X, Sundaram K, Kumar A, Sriwastva MK, Lawrenz MB, Zhang L, Yan J, Feng W, McClain CJ, Zhang X, Zhang HG. Lemon Exosome-like Nanoparticles-Manipulated Probiotics Protect Mice from C. d iff Infection. iScience 2020;23:101571. [PMID: 33083738 DOI: 10.1016/j.isci.2020.101571] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
490 Yoon S, Yu J, McDowell A, Kim SH, You HJ, Ko G. Bile salt hydrolase-mediated inhibitory effect of Bacteroides ovatus on growth of Clostridium difficile. J Microbiol 2017;55:892-9. [PMID: 29076071 DOI: 10.1007/s12275-017-7340-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
491 Tian P, Xu B, Sun H, Li X, Li Z, Wei P. Isolation and gut microbiota modulation of antibiotic-resistant probiotics from human feces. Diagn Microbiol Infect Dis 2014;79:405-12. [PMID: 24820193 DOI: 10.1016/j.diagmicrobio.2014.04.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
492 Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep. 2013;15:337. [PMID: 23852569 DOI: 10.1007/s11894-013-0337-1] [Cited by in Crossref: 143] [Cited by in F6Publishing: 123] [Article Influence: 17.9] [Reference Citation Analysis]
493 Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore DJ, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Goldenberg SD, Williams HRT. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: Joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut. 2018;67:1920-1941. [PMID: 30154172 DOI: 10.1136/gutjnl-2018-316818] [Cited by in Crossref: 126] [Cited by in F6Publishing: 117] [Article Influence: 31.5] [Reference Citation Analysis]
494 Di Bella S, Gouliouris T, Petrosillo N. Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients. J Infect Chemother. 2015;21:230-237. [PMID: 25703532 DOI: 10.1016/j.jiac.2015.01.011] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
495 van Nood E, Speelman P, Nieuwdorp M, Keller J. Fecal microbiota transplantation: facts and controversies. Curr Opin Gastroenterol. 2014;30:34-39. [PMID: 24241245 DOI: 10.1097/mog.0000000000000024] [Cited by in Crossref: 64] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
496 Guo W, Ren K, Ning R, Li C, Zhang H, Li D, Xu L, Sun F, Dai M. Fecal microbiota transplantation provides new insight into wildlife conservation. Global Ecology and Conservation 2020;24:e01234. [DOI: 10.1016/j.gecco.2020.e01234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
497 Kim HB, Zhang Q, Sun X, Beamer G, Wang Y, Tzipori S. Beneficial effect of oral tigecycline treatment on Clostridium difficile infection in gnotobiotic piglets. Antimicrob Agents Chemother 2014;58:7560-4. [PMID: 25267665 DOI: 10.1128/AAC.03447-14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
498 Allegretti JR, Kassam Z, Chan WW. Small Intestinal Bacterial Overgrowth: Should Screening Be Included in the Pre-fecal Microbiota Transplantation Evaluation? Dig Dis Sci 2018;63:193-7. [PMID: 29188472 DOI: 10.1007/s10620-017-4864-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
499 Link A, Lachmund T, Schulz C, Weigt J, Malfertheiner P. Endoscopic peroral jejunal fecal microbiota transplantation. Dig Liver Dis 2016;48:1336-9. [PMID: 27575658 DOI: 10.1016/j.dld.2016.08.110] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
500 Walker AW, Lawley TD. Therapeutic modulation of intestinal dysbiosis. Pharmacol Res. 2013;69:75-86. [PMID: 23017673 DOI: 10.1016/j.phrs.2012.09.008] [Cited by in Crossref: 102] [Cited by in F6Publishing: 88] [Article Influence: 10.2] [Reference Citation Analysis]
501 Cheng YW, Phelps E, Ganapini V, Khan N, Ouyang F, Xu H, Khanna S, Tariq R, Friedman-Moraco RJ, Woodworth MH, Dhere T, Kraft CS, Kao D, Smith J, Le L, El-Nachef N, Kaur N, Kowsika S, Ehrlich A, Smith M, Safdar N, Misch EA, Allegretti JR, Flynn A, Kassam Z, Sharfuddin A, Vuppalanchi R, Fischer M. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. Am J Transplant 2019;19:501-11. [PMID: 30085388 DOI: 10.1111/ajt.15058] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 12.8] [Reference Citation Analysis]
502 Vincent Y, Manji A, Gregory-Miller K, Lee C. A Review of Management of Clostridium difficile Infection: Primary and Recurrence. Antibiotics (Basel) 2015;4:411-23. [PMID: 27025632 DOI: 10.3390/antibiotics4040411] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
503 Spinner JA, Bocchini CE, Luna RA, Thapa S, Balderas MA, Denfield SW, Dreyer WJ, Nagy-Szakal D, Ihekweazu FD, Versalovic J, Savidge T, Kellermayer R. Fecal microbiota transplantation in a toddler after heart transplant was a safe and effective treatment for recurrent Clostridiodes difficile infection: A case report. Pediatr Transplant 2020;24:e13598. [PMID: 31617299 DOI: 10.1111/petr.13598] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
504 Vyas D, L’Esperance HE, Vyas A. Stool therapy may become a preferred treatment of recurrent Clostridium difficileWorld J Gastroenterol 2013; 19(29): 4635-4637 [PMID: 23922461 DOI: 10.3748/wjg.v19.i29.4635] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
505 Hourigan SK, Oliva-Hemker M. Fecal microbiota transplantation in children: a brief review. Pediatr Res. 2016;80:2-6. [PMID: 26982451 DOI: 10.1038/pr.2016.48] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
506 Ren RR, Sun G, Yang YS, Peng LH, Wang SF, Shi XH, Zhao JQ, Ban YL, Pan F, Wang XH, Lu W, Ren JL, Song Y, Wang JB, Lu QM, Bai WY, Wu XP, Wang ZK, Zhang XM, Chen Y. Chinese physicians’ perceptions of fecal microbiota transplantation. World J Gastroenterol 2016; 22(19): 4757-4765 [PMID: 27217707 DOI: 10.3748/wjg.v22.i19.4757] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
507 Vaishnavi C. Fecal microbiota transplantation for management of Clostridium difficile infection. Indian J Gastroenterol 2014;33:301-7. [PMID: 24748025 DOI: 10.1007/s12664-014-0459-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
508 Fischer M, Sipe B, Cheng YW, Phelps E, Rogers N, Sagi S, Bohm M, Xu H, Kassam Z. Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach. Gut Microbes. 2017;8:289-302. [PMID: 28001467 DOI: 10.1080/19490976.2016.1273998] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 14.7] [Reference Citation Analysis]
509 Ji B, Nielsen J. From next-generation sequencing to systematic modeling of the gut microbiome. Front Genet 2015;6:219. [PMID: 26157455 DOI: 10.3389/fgene.2015.00219] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 6.7] [Reference Citation Analysis]
510 Friedman-Korn T, Livovsky DM, Maharshak N, Aviv Cohen N, Paz K, Bar-Gil Shitrit A, Goldin E, Koslowsky B. Fecal Transplantation for Treatment of Clostridium Difficile Infection in Elderly and Debilitated Patients. Dig Dis Sci. 2018;63:198-203. [PMID: 29134299 DOI: 10.1007/s10620-017-4833-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
511 Chen B, Avinashi V, Dobson S. Fecal microbiota transplantation for recurrent clostridium difficile infection in children. J Infect 2017;74 Suppl 1:S120-7. [PMID: 28646951 DOI: 10.1016/S0163-4453(17)30202-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
512 Lo Vecchio A, Cohen MB. Fecal microbiota transplantation for Clostridium difficile infection: benefits and barriers. Curr Opin Gastroenterol. 2014;30:47-53. [PMID: 24275671 DOI: 10.1097/mog.0000000000000023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
513 Butler MI, Mörkl S, Sandhu KV, Cryan JF, Dinan TG. The Gut Microbiome and Mental Health: What Should We Tell Our Patients?: Le microbiote Intestinal et la Santé Mentale : que Devrions-Nous dire à nos Patients? Can J Psychiatry 2019;64:747-60. [PMID: 31530002 DOI: 10.1177/0706743719874168] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
514 Zamudio-tiburcio Á, Bermúdez-ruiz H, Lezama-guzmán HR, Guevara-ortigoza MDP, Islas-solares E, Sosa-lópez FA. Rompiendo paradigmas. Trasplante de microbiota intestinal: reporte preliminar. Cirugía y Cirujanos 2017;85:6-12. [DOI: 10.1016/j.circir.2016.11.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
515 Varier RU, Biltaji E, Smith KJ, Roberts MS, Kyle Jensen M, LaFleur J, Nelson RE. Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection. Infect Control Hosp Epidemiol 2015;36:438-44. [PMID: 25782899 DOI: 10.1017/ice.2014.80] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 7.7] [Reference Citation Analysis]
516 Lai CY, Sung J, Cheng F, Tang W, Wong SH, Chan PKS, Kamm MA, Sung JJY, Kaplan G, Chan FKL, Ng SC. Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation. Aliment Pharmacol Ther. 2019;49:354-363. [PMID: 30628108 DOI: 10.1111/apt.15116] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 13.0] [Reference Citation Analysis]
517 Kelly CR, Kunde SS, Khoruts A. Guidance on preparing an investigational new drug application for fecal microbiota transplantation studies. Clin Gastroenterol Hepatol. 2014;12:283-288. [PMID: 24107393 DOI: 10.1016/j.cgh.2013.09.060] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
518 Pushpanathan P, Mathew GS, Selvarajan S, Seshadri KG, Srikanth P. Gut microbiota and its mysteries. Indian J Med Microbiol 2019;37:268-77. [PMID: 31745030 DOI: 10.4103/ijmm.IJMM_19_373] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 10.5] [Reference Citation Analysis]
519 Ma Y, Liu J, Rhodes C, Nie Y, Zhang F. Ethical Issues in Fecal Microbiota Transplantation in Practice. Am J Bioeth. 2017;17:34-45. [PMID: 28430065 DOI: 10.1080/15265161.2017.1299240] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
520 Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 2012;8:e1002995. [PMID: 23133377 DOI: 10.1371/journal.ppat.1002995] [Cited by in Crossref: 393] [Cited by in F6Publishing: 351] [Article Influence: 39.3] [Reference Citation Analysis]
521 Fujimoto K, Uematsu S. Vaccine therapy for dysbiosis-related diseases. World J Gastroenterol 2020; 26(21): 2758-2767 [PMID: 32550752 DOI: 10.3748/wjg.v26.i21.2758] [Reference Citation Analysis]
522 Liubakka A, Vaughn BP. Clostridium difficile Infection and Fecal Microbiota Transplant. AACN Adv Crit Care. 2016;27:324-337. [PMID: 27959316 DOI: 10.4037/aacnacc2016703] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
523 Davidovics ZH, Michail S, Nicholson MR, Kociolek LK, Pai N, Hansen R, Schwerd T, Maspons A, Shamir R, Szajewska H, Thapar N, de Meij T, Mosca A, Vandenplas Y, Kahn SA, Kellermayer R; FMT Special Interest Group of the North American Society of Pediatric Gastroenterology Hepatology, Nutrition, the European Society for Pediatric Gastroenterology Hepatology, Nutrition. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2019;68:130-43. [PMID: 30540704 DOI: 10.1097/MPG.0000000000002205] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 21.5] [Reference Citation Analysis]
524 Albanese D, De Filippo C, Cavalieri D, Donati C. Explaining diversity in metagenomic datasets by phylogenetic-based feature weighting. PLoS Comput Biol 2015;11:e1004186. [PMID: 25815895 DOI: 10.1371/journal.pcbi.1004186] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
525 Moutsoglou DM. 2021 ATS BEAR Cage Winning Proposal: Microbiome Transplant in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2021. [PMID: 34758276 DOI: 10.1164/rccm.202108-1833ED] [Reference Citation Analysis]
526 Pothuraju R, Chaudhary S, Rachagani S, Kaur S, Roy HK, Bouvet M, Batra SK. Mucins, gut microbiota, and postbiotics role in colorectal cancer. Gut Microbes 2021;13:1974795. [PMID: 34586012 DOI: 10.1080/19490976.2021.1974795] [Reference Citation Analysis]
527 Collini PJ, Kuijper E, Dockrell DH. Clostridium Difficile Infection in Patients with HIV/AIDS. Curr HIV/AIDS Rep 2013;10:273-82. [DOI: 10.1007/s11904-013-0162-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
528 Bewick S, Gurarie E, Weissman JL, Beattie J, Davati C, Flint R, Thielen P, Breitwieser F, Karig D, Fagan WF. Trait-based analysis of the human skin microbiome. Microbiome 2019;7:101. [PMID: 31277701 DOI: 10.1186/s40168-019-0698-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
529 Gu L, Ding C, Tian H, Yang B, Zhang X, Hua Y, Zhu Y, Gong J, Zhu W, Li J, Li N. Serial Frozen Fecal Microbiota Transplantation in the Treatment of Chronic Intestinal Pseudo-obstruction: A Preliminary Study. J Neurogastroenterol Motil 2017;23:289-97. [PMID: 27840368 DOI: 10.5056/jnm16074] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
530 Messer JS, Chang EB. Microbial Physiology of the Digestive Tract and Its Role in Inflammatory Bowel Diseases. Physiology of the Gastrointestinal Tract. Elsevier; 2018. pp. 795-810. [DOI: 10.1016/b978-0-12-809954-4.00036-0] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
531 Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, Moore T, Wu G. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology. 2015;149:223-237. [PMID: 25982290 DOI: 10.1053/j.gastro.2015.05.008] [Cited by in Crossref: 326] [Cited by in F6Publishing: 294] [Article Influence: 46.6] [Reference Citation Analysis]
532 Adamkova P, Hradicka P, Gancarcikova S, Kassayova M, Ambro L, Bertkova I, Maronek M, Farkasova Iannaccone S, Demeckova V. Single Donor FMT Reverses Microbial/Immune Dysbiosis and Induces Clinical Remission in a Rat Model of Acute Colitis. Pathogens 2021;10:152. [PMID: 33540919 DOI: 10.3390/pathogens10020152] [Reference Citation Analysis]
533 Schepici G, Silvestro S, Bramanti P, Mazzon E. The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials. Cell Transplant 2019;28:1507-27. [PMID: 31512505 DOI: 10.1177/0963689719873890] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
534 Bekkers M, Stojkovic B, Kaiko GE. Mining the Microbiome and Microbiota-Derived Molecules in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:11243. [PMID: 34681902 DOI: 10.3390/ijms222011243] [Reference Citation Analysis]
535 Dean AD, Horsburgh MJ, Vasiev B. Toxin-mediated competition in weakly motile bacteria. J Theor Biol 2019;480:205-17. [PMID: 31348925 DOI: 10.1016/j.jtbi.2019.07.013] [Reference Citation Analysis]
536 Austin M, Mellow M, Tierney WM. Fecal microbiota transplantation in the treatment of Clostridium difficile infections. Am J Med 2014;127:479-83. [PMID: 24582877 DOI: 10.1016/j.amjmed.2014.02.017] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
537 Vaughn BP, Rank KM, Khoruts A. Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease. Clin Gastroenterol Hepatol. 2019;17:353-361. [PMID: 30055267 DOI: 10.1016/j.cgh.2018.07.026] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
538 Dodin M, Katz DE. Faecal microbiota transplantation for Clostridium difficile infection. Int J Clin Pract 2014;68:363-8. [DOI: 10.1111/ijcp.12320] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
539 Cammarota G, Ianiro G, Bibbò S, Gasbarrini A. Fecal microbiota transplantation: a new old kid on the block for the management of gut microbiota-related disease. J Clin Gastroenterol 2014;48 Suppl 1:S80-4. [PMID: 25291136 DOI: 10.1097/MCG.0000000000000244] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
540 Pacheco SM, Johnson S. Important clinical advances in the understanding of Clostridium difficile infection. Curr Opin Gastroenterol 2013;29:42-8. [PMID: 23207596 DOI: 10.1097/MOG.0b013e32835a68d4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]